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Summary
Chromatin is the packaged form of DNA in the eukaryotic nucleus, with the nucleosome as
its basic unit. The nucleosome consists of DNA, wrapped around a histone octamer which is
comprised of two copies of each of the four core histones H2A, H2B, H3 and H4. To allow
DNA-related processes to occur, access to the DNA has to be regulated. One regulatory
mechanism is the exchange of the canonical core histones by one of their replacement vari-
ants. Thus far, five members of the histone H3 family have been described: H3.1, H3.2,
H3.3, testis-specific tH3 and centromere-specific CENP-A. Searching the database, we have
recently identified two novel histone H3 variant genes on human chromosome 5, now termed
H3.X and H3.Y. In my PhD thesis, I have analyzed their expression patterns, characterized
their mRNA as well as their protein products and investigated their potential function(s).
H3.X and H3.Y constitute primate-specific genes which have been found, in addition to hu-
mans, also in the chimpanzee and the macaque, but not in other mammals or even lower
eukaryotes. H3.X and especially H3.Y mRNA is expressed at low but significant levels in the
human osteosarcoma cell line U2OS and in some human bone, breast, lung and ovary tumor
tissues, as well as in testis and certain areas of the brain. Tagged H3.X and H3.Y proteins
behave similar to H3.1, H3.2 and H3.3 in their nuclear localization and stable incorporation
into chromatin. However, in contrast to H3.1 and H3.3, novel H3 variants primarily form
heterotypic nucleosomes. Endogenous H3.Y protein is expressed in a small number of U2OS
cells (<0.1%), localizes to the nucleus and constitutes a stable chromatin component. The
number of H3.Y-expressing U2OS cells can be increased by specific stress conditions, such as
nutritional stress paired with high cell density. Matching its expression pattern in U2OS cells,
H3.X and/or H3.Y protein(s) have also been observed in a small subpopulation of neurons in
the human hippocampus. H3.Y has an influence on the expression of certain genes, most of
them being implicated in regulating the cell cycle and chromatin structure. In line with this
finding, knockdown of H3.X and H3.Y impairs cell growth.
In conclusion, the results of this work show that H3.Y (and maybe H3.X) are novel primate-
specific histone H3 variants which play a role in cell cycle regulation. Their expression is
induced by certain stress stimuli and their presence in brain and testis suggests a potential
role in primate-specific brain functions and speciation.
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Zusammenfassung
Chromatin ist die Verpackungsform der DNS im eukaryontischen Zellkern, mit dem Nukleo-
som als kleinster Einheit. Das Nukleosom besteht aus DNS, die um ein Histon-Oktamer,
bestehend aus je zwei Kopien der vier Kernhistone H2A, H2B, H3 and H4, gewickelt ist.
Um DNS-basierte Prozesse zu ermo¨glichen, muss der Zugang zur DNS reguliert werden. Ein
Mechanismus dafu¨r ist der Austausch der kanonischen Histone durch eine ihrer Varianten.
Bislang wurden fu¨nf Mitglieder der Histon H3 Familie beschrieben: H3.1, H3.2, H3.3, tH3,
das nur im ma¨nnlichen Reproduktionsorgan vorkommt und CENP-A, das an den Zentromeren
der Chromosomen zu finden ist. Durch eine Datenbanksuche, konnten wir vor Kurzem im Hu-
mangenom zwei neue Histon H3 Variantengene auf Chromosom 5 identifizieren, die jetzt als
H3.X and H3.Y bezeichnet werden. Wa¨hrend meiner Doktorarbeit habe ich ihre Expressions-
muster analysiert, die von ihnen kodierte mRNA, sowie das zugeho¨rige Protein charakterisiert
und ihre potentielle(n) Funktion(en) untersucht.
H3.X and H3.Y sind primaten-spezifische Gene, die, außer im Menschen, auch im Schim-
pansen und im Rhesusaffen, jedoch nicht in anderen Sa¨ugetieren oder niedrigeren Eukaryonten
gefunden wurden. H3.X- und insbesondere H3.Y-mRNA wird in geringen aber dennoch sig-
nifikanten Mengen in der humanen Osteosarkoma Zelllinie U2OS und in einigen humanen
Knochen-, Brust-, Lungen- und Eierstock-Tumorgeweben, sowie im Hoden und bestimmten
Hirnarealen exprimiert. Epitop-markierte H3.X- und H3.Y-Proteine verhalten sich a¨hnlich
wie H3.1, H3.2 und H3.3 bezu¨glich ihrer Lokalisierung im Zellkern und ihrem stabilen Ein-
bau ins Chromatin. Im Gegensatz zu H3.1 und H3.3, bilden die neuen H3 Varianten jedoch
vorzugsweise heterotypische Nukleosomen. Endogenes H3.Y-Protein wird in einer kleinen
Anzahl von U2OS-Zellen (<0.1%) exprimiert, es befindet sich im Zellkern und stellt einen
stabilen Bestandteil des Chromatins dar. Die Anzahl H3.Y-exprimierender U2OS-Zellen kann
durch spezifische Stress-Stimuli erho¨ht werden, beispielsweise durch Nahrungsmangel gepaart
mit hoher Zelldichte. Vergleichbar mit dem Expressionsmuster in U2OS-Zellen, konnten H3.X
und/oder H3.Y-Protein(e) auch in einer kleinen neuronalen Subpopulation im humanen Hip-
pocampus detektiert werden. H3.Y beeinflusst die Expression bestimmter Gene, von denen
die meisten an der Regulation des Zellzyklus sowie der Struktur des Chromatins beteiligt
sind. In U¨bereinstimmung mit diesem Befund, ist das Wachstum von Zellen mit vermin-
derten Mengen H3.X und H3.Y beeintra¨chtigt.
Zusammengenommen zeigen diese Ergebnisse dass H3.Y (und vielleicht auch H3.X) neue
primaten-spezifische Histon H3 Varianten sind, die an der Zellzyklus-Regulation beteiligt
sind. Ihre Expression wird durch bestimmte Stress-Stimuli induziert und ihr Vorkommen in
Gehirn- und Hodengewebe spricht fu¨r eine potentielle Rolle in primaten-spezifischen Hirn-
funktionen sowie der Artenbildung.
3

1 Introduction
1.1 Chromatin
Chromatin is the packaged form of DNA in the eukaryotic nucleus (van Holde, 1988). On the
first level of compaction, DNA is wrapped around an octamer consisting of two copies of each
of the four core histones H2A, H2B, H3 and H4. This structure, the nucleosome, organizes
146 bp of DNA in 1.65 turns, forming a flat, left-handed superhelix (Fig. 1.1A). The four
core histones have an unstructured N-terminal tail, which is enriched in basic amino acids,
a globular domain and a short C-terminus. Their globular or histone-fold domains (HFDs)
share a highly similar structure consisting of three α-helices (α1 -α3) connected by two loops
(L1 and L2). These domains fold together in antiparallel pairs: H3 with H4, and H2A with
H2B. The assembly of the nucleosome is thought to start with an (H3-H4)2 tetramer, held
together by a strong four helix bundle (4HB) between the two H3 molecules, (H3 and H3’
in Fig. 1.1B) and is completed by the addition of two H2A-H2B dimers. The interaction
A B
Figure 1.1. Crystal structure of the nucleosome.
Depicted are ribbon traces of the 146 bp DNA molecules (brown and turquoise) and the core histones H2A
(yellow), H2B (red), H3 (blue) and H4 (green). (A) The complete nucleosome core particle is shown with the
view down the DNA superhelix axis (left) and perpendicular to it (right). In both cases the pseudo-twofold
axis is aligned vertically with the DNA center at the top. (B) The 73-bp half of the nucleosome core particle
is shown with the view down the superhelix axis and the pseudodyad axis aligned vertically. Histone proteins
primarily associated with the 73-bp superhelix half are depicted (without interparticle tail regions). The two
copies of each histone pair are distinguished as unprimed and primed (e.g. H3 and H3’). 4HBs are labeled as
H3’ H3 and H2B H4; HFD extensions of H3 and H2B are labeled as αN’, αN and αC, respectively; N- and
C-terminal tail regions as N or C. Images adapted from Luger et al., 1997 (modified).
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between H2A-H2B dimers and the (H3-H4)2 tetramer is mediated by weak 4HBs between the
α2 and α3 helices of H2B and H4 (Fig. 1.1B) (Luger et al., 1997). To achieve higher levels of
compaction, the nucleosome core particle is bound by one molecule of the linker histone H1,
forming a chromatosome (Fig. 1.2) and organizing additional 15 to 20 bp of DNA (Simpson,
1978). H1 has a different structure than the core histones, consisting of a conserved globular
domain with long N- and C-terminal tails. Its C-terminus is enriched in lysines and strongly
interacts with DNA. It is well accepted that H1 binds the nucleosome at the DNA entry/exit
site at or near the dyad axis, however, its precise binding site is still controversial (Happel and
Doenecke, 2009; Woodcock and Ghosh, 2010). Although more than 80% of the nucleosomes
have H1 bound at a given time, H1 is highly mobile, binding nucleosomes only transiently
and translocating from one to the other every few minutes (Bustin et al., 2005; Happel and
Doenecke, 2009). The next level of chromatin compaction is the formation of the 30 nm fiber
(Fig. 1.2), a conformation which is transcriptionally inactive. Albeit investigated in numerous
studies, the structure of this fiber remains elusive. The two major models currently being
discussed are a solenoid structure, where the order of the nucleosomes follows their sequence
along the DNA, or a zigzag structure, where odd and even numbered nucleosomes build
separate stacks (Staynov, 2008). Even less is known about higher order chromatin structures,
finally leading to a 10000- to 20000-fold higher DNA compaction in metaphase chromosomes
(Fig. 1.2) (Woodcock and Ghosh, 2010).
DNA
30 nm fiber 
10 nm fiber 
Nucleosome
Metaphase
chromosome
H1
H3
H4H2B
H2A
Chromatosome
Figure 1.2. Chromatin - composition and compaction.
The basic unit of chromatin is the nucleosome, consisting of DNA, wrapped around an octamer of two copies
of each of the four core histones H2A (yellow), H2B (red), H3 (blue) and H4 (green). For further compaction,
one molecule of the linker histone H1 (gray) can be bound, resulting in a chromatosome. Nucleosomes with
linker DNA constitute the 10 nm fiber, which can be further compacted by stacking of nucleosomes, leading to
the 30 nm fiber. Little is known about higher-order chromatin structures finally leading to a condensation of
the genetic material to the level of metaphase chromosomes. Image adapted from Qiu, 2006 (modified).
6
Epigenetic regulation
1.2 Epigenetic regulation
Except for short stretches of DNA, the genetic information in eukaryotes is associated with
histones and packed more or less tightly in higher order structures (see section 1.1). Regions
with a more open chromatin structure constitute euchromatin, whereas tightly packed regions
are known as constitutive or facultative heterochromatin. Constitutive heterochromatin, such
as pericentric heterochromatin, is always silenced. In contrast, facultative heterochromatin
is only silenced in certain contexts, for example as part of the inactive X chromosome (Xi)
in female mammals. For all DNA-related process, such as transcription or replication, chro-
matin structure and DNA accessibility have to be regulated. To meet this need, several
epigenetic mechanisms have evolved, the major ones being DNA methylation, posttransla-
tional modification (PTM) of histones, incorporation (or replacement) of histone variants,
nucleosome-remodeling, non-coding RNAs (ncRNAs) and the position within the nucleus
(nuclear architecture) (Fig. 1.3) (Bo¨nisch et al., 2008). The term epigenetics has been coined
by Conrad Waddington in 1942 for ”the branch of biology which studies the causal interac-
tions between genes and their products, which bring the phenotype into being” (Waddington,
1942; Goldberg et al., 2007). Today, epigenetics is usually defined as heritable changes in
genome function that occur without changes in the DNA sequence (Probst et al., 2009).
DNA methylation, which denotes the addition of a methyl group to the C-5 position of cy-
tosines, is implicated in long-term silencing. Methylated DNA is therefore often found in
heterochromatic regions. During early development, after all methyl marks have been erased,
methylation patterns are established de novo, marking different sites in the maternal and the
paternal genome (imprinting). In somatic mammalian cells, methylation occurs symmetri-
cally at CpG dinucleotides, enabling the maintenance DNA methyltransferase Dnmt1 to copy
the marks after replication, thereby maintaining the silenced state of the underlying DNA
sequence (Bo¨nisch et al., 2008; Espada and Esteller, 2010).
Histones can be posttranslationally modified, primarily on their N-terminal tails. So far,
acetylation, methylation, phosphorylation, ubiquitination, SUMOylation and ADP ribosyla-
tion have been described as major marks (Cosgrove, 2007). PTMs are transferred by ”writer”
and removed by ”eraser” enzymes (Fig. 1.3). They act by either changing the charge of a
residue, thereby influencing its affinity for the DNA or adjacent nucleosomes, or they estab-
lish high-affinity sites for specific ”reader” molecules (Fig. 1.3). While acetylation has been
generally linked to gene activiation, the function of methylation marks depends on the actual
residue. Methylated H3 lysine (K) 4 and H3K36, for example, are found in euchromatic re-
gions whereas methylated H3K9, H3K27 and H4K20 constitute heterochromatic marks (Fuchs
et al., 2006). Moreover, histones can carry several different PTMs at the same time, estab-
7
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lishing a possible histone-code (Strahl and Allis, 2000; Turner, 2000), which has a different
readout than each modification alone. This combinatorial action of histone PTMs also ex-
plains how for instance the phosphorylation of H3S10 can promote such different processes
as the induction of immediate-early genes (Clayton and Mahadevan, 2003) and the conden-
sation of chromosomes during cell division (Wei et al., 1999; Hendzel et al., 1997). Adding
another level of complexity, histones cannot only be modified but also exchanged with one
of their replacement variants. These proteins can on the one hand influence the structure
and stability of the nucleosome and offer on the other hand alternative modification sites due
to sequence differences. The four core histones and the linker histone H1 show variation to
different extents. For a more detailed overview see section 1.3.
To move nucleosomes and allow access to nucleosomal DNA, several ATP-dependent nucleo-
some remodeling complexes have evolved, each containing an ATPase of the SWI/SNF-family.
Depending on the ATPase subtype and the factors associated with it, these complexes catalyze
the partial or complete dissasembly of nucleosomes (histone eviction) or the repositioning of
DNA methylation
Non-coding RNAs Histone PTMs
Nuclear architecture
EPIGENETIC
REGULATION
Nucleosome remodeling
Me MeMe
MeMe Me
Histone variants
MOF
MLE
MSL2MSL1
MSL3
roX 1/2
RNA
Reader
Writer
Eraser
Figure 1.3. Epigenetic regulation.
Schematic overview depicting major epigenetic regulatory processes which act on different levels. DNA is
methylated on specific cytosines. Histones, organizing DNA in nucleosomes, can be posttranslationally modi-
fied by ”writer” enzymes, thereby changing the charge and/or the binding site for specific ”reader” molecules.
PTMs can also be removed by ”eraser” enzymes. In addition, histones can be exchanged by histone variants
with different sequences, resulting in a change of structural properties and PTM sites. Accessibility of chro-
matinized DNA can be regulated by ATP-dependent nucleosome remodeling, for example shifting or evicting
nucleosomes. NcRNAs are implicated in diverse processes. Examples are the roX1/2 RNAs in the Drosophila
dosage compensation complex and Xist RNA, implicated in X chromosome inactivation in mammals. Not only
the packaging of DNA is important for DNA-related processes, but also the localization within the nucleus.
Histone gene clusters for instance, localize to nuclear Cajal bodies where specific histone mRNA processing
factors are concentrated. All of these processes do not act alone but are interconnected. See text for details.
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nucleosomes along the DNA (nucleosome sliding) (Fig. 1.3) (Becker and Ho¨rz, 2002; Saha
et al., 2006). Nucleosomes, which have histone H1 bound, can also be remodeled, but only
by some of the complexes (Maier et al., 2008). It is important to mention that remodelers
do not just increase the accessibility of the DNA but can also establish repressive chromatin
states (Becker and Ho¨rz, 2002; Saha et al., 2006).
NcRNAs are a diverse class of molecules, differing in size, structure and function. They can
influence gene expression levels, either acting post-transcriptionally or directly influencing
transcription. One example for the latter is the RNA-induced initiation of transcriptional
gene silencing (RITS) complex in Schizosaccharomyces pombe, which is targeted to homolo-
gous sequences by small ncRNAs and mediates the formation of heterochromatin (Bernstein
and Allis, 2005). In addition, long ncRNAs, such as Xist, which is implicated in X chromo-
some inactivation in female mammals (Bernstein and Allis, 2005), HOTAIR, which silences
certain HOX genes in humans (Rinn et al., 2007) and roX1/2, components of the dosage
compensation complex in flies, mediating the two-fold activation of the single male X chro-
mosome (Fig. 1.3) (Bernstein and Allis, 2005), have been described. Taking into account that
most of the genome is actually transcribed (Gerstein et al., 2007), future studies will certainly
reveal more regulatory ncRNAs, maybe also acting by completely different mechanisms.
Within the nucleus, sub-structures can be observed, which lack a demarcating membrane and
are instead defined by the presence of a certain set of proteins (e.g. Cajal or PML bodies).
Moreover, in interphase cells, chromosomes adopt distinct territories, the position of which
seems to be dependent on chromosome size, gene density and morphology. Despite some re-
cent studies showing on the one hand that in human cells localization of genes to the nuclear
periphery influences their expression and explaining on the other hand some long-range inter-
actions of specific loci in detail, the general mechanisms how nuclear architecture influences
gene expression are still unknown (Schneider and Grosschedl, 2007; Nunez et al., 2009).
Although all of these mechanisms can function independently, in most cases several of them
act together to establish and maintain a certain chromatin state (Bo¨nisch et al., 2008). One
prominent example illustrating this complexity, is the X inactivation in female mammals,
where one X chromosome is silenced through the concerted action of DNA methylation, his-
tone PTMs, histone variants and ncRNAs.
1.3 Histone variants
The core histones H2A, H2B, H3 and H4 and the linker histone H1 show variation to a differ-
ent extent. Since this variation is not only dependent on the protein but also on the species,
this overview focuses on mammalian and in particular human histone variants.
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Histone variants fall into two groups, canonical histones and replacement variants. The genes
encoding canonical histone proteins are intron-free, replication-dependently expressed, orga-
nized in multi-copy clusters and their mRNAs have a conserved stem-loop structure at the 3’
end instead of a poly(A) tail. This unique 3’ structure, together with the stem loop binding
protein (SLBP), is responsible for the processing, translation and degradation of canonical
histone mRNAs. They thereby ensure high expression levels throughout S-phase, when large
amounts of histones are needed for replication, followed by a rapid degradation at the end.
Histone gene clusters typically contain multiple copies of each of the genes encoding for the
five different histone proteins. A possible reason for this organization is that it allows them
to be brought together in a domain enriched in factors required for their expression, the Cajal
bodies in mammals. In contrast, replacement variants are encoded by solitary genes (or have
only a few copies) outside of histone gene clusters. They usually contain introns, their mRNA
is polyadenylated and they are expressed throughout the whole cell cycle (Marzluff et al.,
2008).
For H4, no variants have been identified in mammals up to now (Table 1.1 and Fig. 1.4D).
The reason for this lack of variation is presumably that H4 interacts with all other histones
in the octamer, leaving little room for structural changes (Luger et al., 1997). In the follow-
ing sections, the four other histone families are introduced and the diverse functions of their
members described. For a summary of the data presented about core histone variants, see
Table 1.1.
1.3.1 H1 variants
The linker histone H1 family shows high variability but the number of H1 variants differs
extremely between species. In mammals for example, 11 H1 variants have been identified,
while Drosophila melanogaster has only one. Focusing on human H1 variants, differences in
temporal and spatial expression (Izzo et al., 2008), ability to bind and condense chromatin
(Clausell et al., 2009), as well as localization to eu- or heterochromatic areas (Th’ng et al.,
2005) have been reported. H1.1 -H1.5 and H1t are replication-dependently expressed and
part of histone gene clusters whereas genes encoding replacement variants such as H1.0 are
found outside of these clusters and are expressed independent of replication (Happel and
Doenecke, 2009; Izzo et al., 2008). H1.2-H1.5 are present in all somatic cells with H1.2 and
H1.4 being the predominant forms in most of the cells. In contrast, H1.0 is mainly expressed
in terminally differentiated cells and H1.1 expression has so far only been reported for certain
tissues (Meergans et al., 1997). H1x is currently the least well characterized of the human H1
variants and its expression has only been analyzed in a limited number of cell types (Happel
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et al., 2005). The four remaining variants constitute a set of germ cell-specific proteins with
H1oo being expressed in oocytes and H1t, H1T2 and HILS1 in testis (Happel and Doenecke,
2009; Izzo et al., 2008). Regarding H1.0-H1.5, it could be shown that they differ in their
sub-cellular localization and that this localization is dependent on their C-terminal domain.
H1.4, for instance, is associated with heterochromatin in most of the cells, whereas H1.2 and
H1.3 are mainly found in euchromatic areas (Th’ng et al., 2005). Using native-like chromatin
in form of minichromosomes, Clausell and coworkers analyzed the ability of human somatic
H1 variants to condensate chromatin, classifying them as weak (H1.1 and H1.2), intermediate
(H1.3) and strong condensers (H1.0, H1.4, H1.5 and H1x) (Clausell et al., 2009). To assess
the biological role of individual variants, knockout studies in mice have been conducted.
Knockout of one of the H1 variants H1.2, H1.3 and H1.4 alone or together with H1.0 did
not show any obvious phenotype. Under these conditions, the remaining subtypes are up-
regulated, compensating and maintaining a normal H1/core nucleosome ratio (Sirotkin et al.,
1995; Fan et al., 2001). However, careful anaylsis of these knockout mice revealed specific
effects in many cases. For H1.0, for instance, it could be shown that it is essential for
the terminal differentiation of dendritic cells (Gabrilovich et al., 2002). Interestingly, triple-
null mice, lacking H1.2, H1.3 and H1.4, die by mid-gestation with a broad range of defects.
The ratio of H1 to nucleosomes is reduced by 50% and the spacing between nucleosomes is
shortened globally (Fan et al., 2003). In embryonic stem (ES) cells derived from these mice,
albeit chromatin structure is changed dramatically, suprisingly the expression of only a small
number of genes is affected. Many of these genes are usually regulated by DNA methylation,
arguing for a role of (some) H1 variants in the establishment or maintenance of specific DNA
methylation patterns (Fan et al., 2005). Depletion of each of the variants H1.0 and H1.2-H1.5
in human breast cancer cells, leads to alterations in a different subset of genes and different
effects on cell cycle. Decreased levels of H1.2 induce G1 arrest in T47D and MCF10A breast
epithelial cell lines and apoptosis in the breast cancer cell line MCF7. Moreover, depletion
of H1.4 causes cell death in T47D cells, providing the first evidence for a crucial role of an
H1 subtype for the survival of human cells (Sancho et al., 2008). In line with these results,
studies in the last couple of years have revealed specific effects of certain H1 variants in other
biological processes. Human 1.2, for example, has been shown to dissociate from chromatin
after occurance of DNA double strand breaks (DSB). It accumulates in the cytoplasm where
it triggers the release of cytochrome c from mitochondria, thereby transmitting apoptotic
signals from the nucleus (Konishi et al., 2003). Further examples for specific roles of H1
variants in different organisms are summarized in Izzo et al., 2008.
Taken together, these data propose two distinct roles for linker histone variants: On the one
hand, H1 variants are redundant in their ability to mediate global chromatin compaction
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and to stabilize higher order chromatin structures. In knockout cells, the loss of a particular
variant can therefore be compensated by the up-regulation of other H1 subtypes. On the other
hand, each variant regulates a subset of specific genes, a role which cannot be compensated
by other variant proteins (Izzo et al., 2008).
Table 1.1. Human core histone variants.
Distribution over species (Distribution), cell cycle expression profile (Expr.), sub-cellular localization (Local-
ization), functional profile (Function) and specific chaperone (Chaperone) are summarized for all human core
histone variants known to date. See text for details. Table, based on Bernstein and Hake (2006) and Talbert
and Henikoff (2010), has been amended and updated with recent findings.
Variant Distribution Expr. Localization Function Chaperone
H2A H2A Widespread RD TG Genome packaging NAP1?
H2A.X Universal RI TG* DNA repair, genome integrity FACT
H2A.Z-1 Universal** RI TG Gene activation, silencing, HIRIP3?
chromosome segregation
H2A.Z-2 Universal** RI TG Gene activation, silencing, HIRIP3?
chromosome segregation
H2A.Bbd.1 Mammals ND Xi exclusion Spermatogenesis, Gene activation? ND
H2A.Bbd.2 Mammals ND Xi exclusion Spermatogenesis, Gene activation? ND
MacroH2A1.1 Animals ND Xi X chr. inactivation, gene silencing? ND
MacroH2A1.2 Animals ND Xi X chr. inactivation, gene silencing? ND
MacroH2A2 Animals ND Xi X chr. inactivation, gene silencing? ND
H2B H2B Widespread RD TG Genome packaging NAP1?
spH2B Human ND Telomeres ND ND
H2BFWT Primates ND Telomeres? Testis-specific, ND
sperm cell number and vitality?
hTSH2B Mammals ND basal part of Testis-specific, pronuclei formation? ND
the nucleus activation of paternal genes?
H3 H3.1 Mammals RD ND Genome packaging CAF-1
H3.2 Widespread RD ND Genome packaging ND
H3.3 Universal RI Genes, TFBS, Gene activation HIRA, Daxx,
telomeres DEK
tH3 Mammals RD? ND Testis-specific, ND NAP2
CENP-A Universal RI Centromeres Chromosome segregation HJURP
H4 H4 Universal RD TG Genome packaging H3 chaperones
ND=not determined, RD= replication dependent, RI= replication independent, TG= throughout genome,
Xi= inactive X chromosome, ?=hypothesized, TFBS= transcription factor binding sites. *) γ-H2A.X
(=H2A.XS139ph) localizes to DNA DSBs and a population of small nuclear foci. **) H2.Z is a universal
variant but only vertebrates have two genes giving rise to two different H2A.Z proteins.
1.3.2 H2A variants
The most variable core histone is H2A, for which four major variants are known to date:
H2A.X, H2A.Z, macroH2A and H2A.Bbd (Barr-body deficient). These proteins show - in
addition to sequence variations - also different lengths compared to canonical H2A.
The universal variant H2A.X is highly similar to H2A but is distinguished by its conserved
C-terminal SQ-motif (Fig. 1.4A). Its unique S139 is phosphorylated at sites of DNA damage
(Rogakou et al., 1998, 1999) by the DNA damage signaling kinases ATM (ataxia telangecta-
sia mutated), ATR (ATM- and Rad3-related) and DNA-Pk (DNA-dependent protein kinase)
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(Burma et al., 2001; Stiff et al., 2004). The phosphorylated form, termed γ-H2A.X, is present
at sites of DSBs during DSB repair, meiotic recombination (Mahadevaiah et al., 2001), apop-
totic digestion (Rogakou et al., 2000), V (D) J splicing (Chen et al., 2000), and class switch
recombination (Petersen et al., 2001). These data suggest γ-H2A.X to be a universal cellular
response to DSBs, functioning in the maintenance of genome stability. Emerging evidence
proposes that γ-H2A.X also plays a role outside DSBs, for example in the replication of fac-
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Figure 1.4. Protein sequences of human core histone variants.
Schematic representation of human core histone variants. Proteins are divided in N-terminal tail and globular
domain with C-terminal tail. Human (A) H2A (yellow), (B) H2B (red), (C) H3 (blue) and (D) H4 (green)
variants are depicted. Highly divergent protein sequences are visualized by different color shades without high-
lighting sequence differences. Amino acid differences are indicated when variants differ only in few key residues
(for example H3 variants) or when variant-specific amino acids are posttranslationally modified (for example
the SQEY-motif in H2A.X). PTM sites are marked as follows: ellipse=phosphorylation, square=methylation,
triangle= acetylation, trapezoid=ubiquitination. The macrodomains of macroH2A histones are not drawn to
scale. Their triangular shape indicates non-histone-like sequences. MacroH2A1.1 and macroH2A1.2 are splice
variants (differentially spliced exon 6), denoted by an internalized white or black triangle in their macrodomain.
Note that spH2B, another H2B variant, is not depicted because its protein sequence has not been identified
yet. See text for details. Image adapted from Bernstein and Hake, 2006, amended with recent findings.
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ultative heterochromatin on the Xi. However, these functions are less well understood and
subject of current research (Ismail and Hendzel, 2008).
The second universal H2A variant is H2A.Z, which shows ∼60% sequence identity to canonical
H2A. H2A.Z plays a role in such diverse processes as gene activation, chromosome segrega-
tion, heterochromatin silencing, and progression through the cell cycle (Zlatanova and Thakar,
2008). Aiming to explain how H2A.Z can fulfill its contrasting functions, several modes of
regulation have been identified. In humans, H2A.Z has been found to be enriched in promoter
regions up- and downstream of transcription start sites with binding levels matching gene ex-
pression (Zlatanova and Thakar, 2008). Furthermore, posttranslational modifications seem to
regulate H2A.Z function as H2A.Z acetylation levels are higher in euchromatic compared to
heterochromatic regions and mono-ubiquitinated H2A.Z, which is found on the Xi, seems to
be important for transcriptional repression (Talbert and Henikoff, 2010). Further variability is
observed in vertebrates, where two isoforms, H2A.Z-1 and H2A.Z-2, that differ in three amino
acids (Fig. 1.4A), are encoded by two different genes (Coon et al., 2005; Dryhurst et al., 2009;
Matsuda et al., 2010). H2A.Z-1 knockout is lethal in mice (Faast et al., 2001) and separate
knockdown of both isoforms results in distinct alterations in cell growth and gene expression
(Matsuda et al., 2010). Moreover, H2A.Z-1 and H2A.Z-2 are differentially expressed in some
tissues and show similar but not identical distributions in chromatin (Dryhurst et al., 2009).
Taken together, these data suggest that H2A.Z-1 and H2A.Z-2 have non-redundant functions
and differential effects on nucleosome stability and chromatin structure.
In 1992, the first of the macroH2A variants was identified, later named macroH2A1.1. Its
N-terminal third is 64% identical to H2A and its C-terminal part (∼30 kDa) constitutes
a macrodomain (Pehrson and Fried, 1992). Its isoform macroH2A1.2, differing in a short
stretch of amino acids in the non-histone domain, originates from the same gene by alterna-
tive splicing (Rasmussen et al., 1999). MacroH2A2, which is 80% identical to macroH2A1.2,
is encoded by a second gene (Fig. 1.4A) (Chadwick and Willard, 2001a). MacroH2A1.2 and
macroH2A2 have different nuclear localization patterns but are both enriched on the Xi
(Costanzi and Pehrson, 1998, 2001; Chadwick and Willard, 2001a), suggesting a role in X
inactivation and, as they are expressed at similar levels also in males (Rasmussen et al.,
1999), maybe as general repressors of transcription. However, several studies could show that
macroH2A is not necessary for X inactivation, thereby also questioning macroH2A’s role as
general repressor (Gamble and Kraus, 2010). Two studies, mapping macroH2A localization
by ChIP-chip, could recently show association of macroH2A with a large number of autosomal
genes. MacroH2A-associated genes are enriched for H3K27me3, a mark for facultative hete-
rochromatin (Buschbeck et al., 2009; Gamble et al., 2010), and consistent with this finding,
most of these genes are transcriptionally silent. However, roughly 20% of macroH2A1-bound
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genes are expressed and, surprisingly, macroH2A1 positively affects about 75% of its target
genes (Gamble et al., 2010). In addition to its role in transcriptional regulation, macroH2A
also seems to play a role in development as all three variants are differentially expressed in
a tissue- and development-dependent manner (Pehrson et al., 1997; Costanzi and Pehrson,
2001). Furthermore, macroH2A may also be implicated in cell proliferation as its association
with the Xi is cell cycle dependent and disrupted by the phosphorylation of S137, which is
dramatically up-regulated during mitosis (Bernstein et al., 2008). Additionally, macroH2A
becomes re-distributed when cells exit the cell cycle (Gamble et al., 2010).
Regarding sequence differences, the most variable H2A variant is the mammalian H2A.Bbd,
which is only 48% identical to H2A. In humans, it is encoded by three intronless genes on
the X chromosome giving rise to two proteins that differ in only one amino acid (Fig. 1.4A)
(Chadwick and Willard, 2001b). H2A.Bbd lacks the H2A C-terminus containing an acidic
patch that directly contacts histone H4 (Luger et al., 1997). None of the PTM-carrying
residues in H2A is present in H2A.Bbd, instead, the protein has a stretch of six arginines
in its N-terminal tail (Fig. 1.4A). Tagged H2A.Bbd is co-localizing with acetylated histone
H4 and excluded from the Xi, suggesting an association with transcriptionally active chro-
matin (Chadwick and Willard, 2001b). Reconstituted nucleosomes containing H2A.Bbd have
a more relaxed conformation (Bao et al., 2004; Gautier et al., 2004; Montel et al., 2007) and
organize only 120 - 130 bp of DNA (Bao et al., 2004; Doyen et al., 2006). H2A.Bbd has been
proposed to constitute an acetylation independent device for the local unfolding of chromatin,
thereby promoting transcription (Eir´ın-Lo´pez et al., 2008). In addition, H2A.Bbd is involved
in spermatogenesis where it probably facilitates the exchange of histones with protamines by
destabilizing the nucleosome and is retained at some sites in sperm cells (Ishibashi et al., 2010).
1.3.3 H2B variants
In the nucleosome, the H3-H4 tetramer interacts with the H2A-H2B dimer through contacts
made by H2B with H4 (Luger et al., 1997). This important structural role of H2B is most
likely the cause for the presence of just three human H2B variants which, in addition, are
restricted to the male germinal cell lineage (Fig. 1.4B and Table 1.1). Although little is known
about all of these variants, maybe the most enigmatic is the human-specific spH2B, which
was discovered as part of a telomere-binding complex. spH2B shows higher electrophoretic
mobility than canonical H2B, binds telomeric DNA in vitro and shows a punctuate localiza-
tion in sperm nuclei, partially coinciding with telomeric DNA (Gineitis et al., 2000).
The most conserved of the human H2B variants is the testis/sperm-specific variant hTSH2B,
an ortholog of the rodent TH2B, which shows 85% similarity to canonical H2B (van Roijen
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et al., 1998; Zalensky et al., 2002). hTSH2B is only expressed in a sub-population of sperm
cells (∼ 30%) where it localizes specifically to the basal part of the nucleus, adjacent to the
sperm tail attachment point. Distinct foci in cells expressing lower hTSH2B levels, propose a
possible association with specific chromatin domains (Singleton et al., 2007; Zalensky et al.,
2002). Expression of hTSH2B promotes a more rapid and comprehensive chromatin decon-
densation, suggesting a potential role in pronuclei formation and the activation of paternal
genes following fertilization and during early embryonic development (Singleton et al., 2007).
On the molecular level, it could be shown that although hTSH2B has a destabilizing effect on
histone octamers, nucleosomes containing this novel variant are structurally and dynamically
indistinguishable from their canonical counterpart (Li et al., 2005). The most pronounced
sequence differences between somatic H2B and hTSH2B are found at the N-terminus (Zalen-
sky et al., 2002), a region which in H2B is involved in interactions with DNA and important
for mitotic and apoptotic condensation of chromosomes (de la Barre et al., 2001; Cheung
et al., 2003). Residues, known to be phosphorylated, are missing or re-positioned and novel
potential phosphorylation sites have been introduced (Kimmins and Sassone-Corsi, 2005).
Interestingly, S14, phosphorylated in H2B by Mst1 kinase during apoptosis (Cheung et al.,
2003), is replaced by a phenylalanine in hTSH2B (Fig. 1.4B), raising the question whether
hTSH2B has the potential to prevent sperm cells from undergoing apoptosis (Bernstein and
Hake, 2006).
In 2004, a primate- and testis-specific H2B variant, termed H2BFWT (H2B family member
W, testis-specific), has been identified. The H2BFWT gene is located on the X chromosome
and encodes a highly divergent H2B variant with only 45% amino acid sequence identity with
somatic H2B. Interestingly, the syntenic region on the mouse X chromosome is considerably
shorter, suggesting that H2BFWT and its paralogs (three to five genes, clustered tightly on
the X chromosome) have either evolved recently in the primate lineage or have been lost
in rodents (Churikov et al., 2004). In a nucleosomal context, H2BFWT behaves similar to
canonical H2B as shown by equal mobilization and remodeling efficiencies using SWI/SNF
on in vitro reconstituted chromatin. This can be explained by the fact that H2BFWT se-
quence mainly differs in the N-terminal tail, whereas the core region, which determines the
nucleosome structure, is more conserved. Although it does not influence overall nucleosome
structure, the altered N-terminus has an effect on H2BFWT behavior as it leaves the protein
unable to recruit chromosome condensation factors and to assist in the assembly of mitotic
chromosomes (Boulard et al., 2006). Regarding the function of this novel variant, initial ex-
periments have shown that H2BFWT partially localizes to the interstitial telomeric blocks,
suggesting a telomere-associated function (Churikov et al., 2004). More recent results link
H2BFWT to male infertility: A single nucleotide polymorphism in the 5’ UTR of H2BFWT
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has been identified, which severly reduces translation of H2BFWT, causing reduced sperm
count and vitality (Lee et al., 2009).
Recently, two novel testis-specific H2B variants (H2BL1 and H2BL2), involved in pericentric
heterochromatin reprogramming during mouse spermatogenesis, have been identified. H2BL1
and H2BL2 are not homologous to any of the described human H2B variants, underlining the
high diversity of testis-specific histone variants (Govin et al., 2007).
1.3.4 H3 variants
In mammals, five histone H3 variants have been described to date: H3.1, H3.2, H3.3, H3.1t
(tH3, testis-specific) and CENP-A (centromere-specific). Except for CENP-A, sequence dif-
ferences are quite subtle among H3 proteins (Fig. 1.4C). H3.1 and H3.2 are distinguished by
a single amino acid exchange at position 96, with H3.1 carrying a cysteine and H3.2 a serine.
Both are replication-dependently expressed, but H3.1 is only found in mammals, whereas
H3.2 is present in all eukaryotes except for budding yeast (Bernstein and Hake, 2006). Due
to their high similarity, they are often treated as one protein. However, quantitative mass
spectrometry analyses have revealed that expression levels and PTM patterns of these vari-
ants vary between different mammalian cell lines and tissues, arguing for distinct protein
species (Hake et al., 2006; Garcia et al., 2008). H3.2 is enriched in di- and trimethylated K27,
modifications associated with transcriptional silencing and marks of facultative heterochro-
matin. In contrast, H3.1 shows enrichment in K9 dimethylation, K64 monomethylation and
K14 acetylation. K9 dimethylation is found in areas of constitutive heterochromatin (Hake
et al., 2006). An interesting hypothesis, aiming to explain the different functions and modes
of action of these H3 variants, is the implication of the unique C96 in H3.1 in intermolecular
disulfide bonds. In this model, H3.1 promotes higher order chromatin structures and silencing
of certain chromatin regions by forming disulfide bonds with neighboring nucleosomes, lamin
B receptor (to retain certain loci at the nuclear periphery) or other yet to be identified factors
(Hake and Allis, 2006).
The universal H3 variant H3.3 shows four amino acids difference compared to H3.2. It is
expressed and incorporated into chromatin throughout the cell cycle and has been found to
be enriched in PTMs associated with active transcription (Bernstein and Hake, 2006). In line
with these findings, many studies in different organisms have mapped H3.3 to the complete
coding region of transcribed genes and to highly enriched foci in promoter regions, estab-
lishing its reputation as activating variant. However, H3.3 also marks inactive genes (maybe
accounting for a ”poised” state of these genes) and genic as well as intergenic regulatory re-
gions (Elsaesser et al., 2010). In addition, H3.3 has been shown to localize to telomeres (Wong
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et al., 2009; Goldberg et al., 2010), is implicated in the establishment of heterochromatin in
the mouse embryo (Santenard et al., 2010) and found associated with pericentromeric het-
erochromatin when its unique serine 31 (Fig. 1.4C) is phosporylated during mitosis (Hake
et al., 2005). Taken together, these data suggest that H3.3 does not simply promote gene
transcription but rather has very distinct functions which depend largely on its incorporation
at specific loci and its interaction partners (see also section 1.3.5).
The mammalian testis-specific H3 variant tH3 differs in four amino acids from H3.1 (Fig. 1.4C)
(Witt et al., 1996). Two of these changes (M71 and V111) have recently been identified to
cause the significantly lower stability of tH3-containing nucleosomes which may be important
for the replacement of histones with protamines during spermatogenesis (Tachiwana et al.,
2010). Although tH3 is primarily expressed in testis, low amounts have also been detected in
HeLa cells (Andersen et al., 2005), mouse embryos and adult mouse brain and spleen (Govin
et al., 2007). The function of this somatic tH3 fraction remains to be determined.
The most divergent of the mammalian H3 variants is CENP-A, which shows only ∼60%
homology to H3 in its histone-fold domain and has a highly variable N-terminus (Sullivan,
2001). CENP-A localizes to the centromere of eukaryotic chromosomes and is essential for
the assembly of the kinetochore, the attachment point of spindle microtubules during cell
division. Although it is still unclear what exactly defines centromere position, several lines
of evidence now suggest that it is determined by epigenetic marks, maybe the most crucial
being the replacement of canonical H3 by CENP-A (Mehta et al., 2010). CENP-A is es-
sential as its knockout in mice is lethal early in development with embryos showing severe
mitotic problems, chromatin fragmentation and hypercondensation (Howman et al., 2000).
In human cells, where depletion of CENP-A causes cell death accompanied by severe mi-
totic defects, a complete rescue can be achieved by replacement with histone H3 carrying
the centromere-targeting domain (CATD) of CENP-A (Black et al., 2007). The CATD is
necessary and sufficient for nucleosome assembly at centromeres and it is responsible for
the unique conformational rigidity of CENP-A-containing nucleosomes (Black et al., 2004,
2007). Several studies have shown that nucleosomes containing centromere-specific histone
H3 (CenH3) have an unusual structure. In Drosophila, for example, they seem to consist of a
heterotetramer of H2A, H2B, CenH3 and H4, rather than an octamer. In addition, it has been
proposed that centromeric nucleosomes organize DNA in a right-handed wrap (Talbert and
Henikoff, 2010). However, the recently solved crystal structure of the CENP-A-H4 tetramer
suggests that CENP-A-containing nucleosomes are octameric with conventional left-handed
DNA wrapping (Sekulic et al., 2010). In summary, CENP-A seems to be the essential epige-
netic factor that marks centromere location by restructuring the nucleosome from within its
globular domain, mediated by the CATD.
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1.3.5 Targeted chromatin incorporation of histone variants
With the growing knowledge about histone variants that partly show very distinct localiza-
tion patterns, the question arose, how they are targeted and incorporated at such specific
chromatin sites. For proteins playing a role in these processes, the term ”histone chaperone”
has been coined (Koning et al., 2007). In the last 30 years, multiple histone chaperones,
implicated in the storage, transport or deposition of a certain variant or a group of histone
proteins, have been described (Koning et al., 2007; Eitoku et al., 2008).
The targeted incorporation of H2A-H2B variant dimers is mediated by several different pro-
teins. NAP1 functions as a shuttle for H2A-H2B from the cytoplasm to the nucleus (Loyola
and Almouzni, 2004). In addition, it was shown to assemble nucleosomes in vitro (Ishimi et al.,
1987, 1984) and to interact with H2A-H2B in vitro and in vivo (Chang et al., 1997; Ishimi
et al., 1987; Ito et al., 1996), suggesting it to be a H2A-H2B-specific chaperone. However,
biochemical studies indicate that NAP1 preferentially binds H3-H4 when all core histones are
present (McBryant et al., 2003; Mazurkiewicz et al., 2006; Eckey et al., 2007), questioning the
specificity of this chaperone for the H2A-H2B dimer. In budding yeast, it has been shown that
Htz (H2A.Z) is deposited by Chz1 together with the SWR1 complex (Luk et al., 2007; Korber
and Ho¨rz, 2004). The conserved CHZ motif confering this function, is also found in human
HIRA-interacting protein 3 (HIRIP3), a factor shown to interact with core histones (Lorain
et al., 1998). In addition, p400/Domino and SRCAP, homologs of the SWR1 complex, have
been identified which are able to exchange H2A-H2B with H2A.Z-H2B dimers (Ge´vry et al.,
2007; Ruhl et al., 2006). It is tempting to speculate that HIRIP3 constitutes the human
H2A.Z-specific chaperone, which together with p400/Domino or SRCAP is responsible for
the site-specific incorporation of H2A.Z. H2A.X deposition could be shown to be mediated
by the FACT complex. Chromatin incorporation is promoted by phosphorylation of H2A.X,
whereas poly-ADP-ribosylation of the FACT subunit Spt16 reduces H2A.X exchange activity
(Heo et al., 2008). For the other known H2A variants, macroH2A and H2A.Bbd, so far, no
specific chaperone has been identified.
In the last couple of years, chaperones for most of the mammalian H3 variants have been
found. H3.1 is deposited by the CAF-1 complex (Tagami et al., 2004) in a DNA-synthesis-
coupled manner. Through the interaction with PCNA, CAF-1 is targeted to the replication
fork (Shibahara and Stillman, 1999; Krude, 1995) and to sites of damaged DNA in UV-treated
cells (Green and Almouzni, 2003; Polo et al., 2006). For H3.2, no specific chaperone has been
described so far, but as it differs in only one amino acid from H3.1 (Fig. 1.4C), it seems likely
that it is also deposited by CAF-1. For several years, it has been clear that the replication-
independent deposition of H3.3 is mediated by HIRA (Tagami et al., 2004). However, several
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recent publications have now shown that the picture is much more complex: HIRA is re-
quired for the incorporation of H3.3 at active and repressed genes, but it is dispensible for
deposition at telomeres and many transcription factor binding sites (Goldberg et al., 2010).
Instead, H3.3 incorporation at telomeres and the repression of telomeric RNA is mediated
by the novel histone chaperone Daxx together with ATRX (Drane´ et al., 2010; Lewis et al.,
2010; Goldberg et al., 2010; Wong et al., 2010). Moreover, phosphorylated DEK, associat-
ing with casein kinase 2, acts as a H3.3 chaperone in flies and humans. In flies, DEK has
been shown to be a co-activator of the nuclear ecdysone receptor. Interestingly, in humans
the deposition of H3.3 is impaired in acute myeloid leukemia patients carrying a chromoso-
mal translocation fusing DEK to CAN (Sawatsubashi et al., 2010). For the testis-specific
variant tH3, nothing is known about its deposition in vivo. However, in vitro, NAP2, a par-
alog of NAP1, efficiently incorporates tH3 into nucleosomes (Tachiwana et al., 2008). Only
recently, the Holliday junction-recognizing protein (HJURP) has been identified as the chap-
erone specifically depositing the centromere-specific H3 protein CENP-A (Dunleavy et al.,
2009; Foltz et al., 2009). Surprisingly, while centromeric DNA is replicated during S-phase,
recruitment of new CENP-A by HJURP in human cells is restricted to a short time window at
late telophase/early G1, leaving the cell with only 50% of the maximal CENP-A nucleosome
complement during G2 and mitosis (Jansen et al., 2007; Hemmerich et al., 2008; Dunleavy
et al., 2009; Foltz et al., 2009). Whether H3 is incorporated instead or these sites remain un-
occupied, is currently unclear, although it is known that H3.1 nucleosomes can be assembled
with alpha-satellite DNA and that they can be found interspersed with CENP-A nucleosomes
(Blower et al., 2002).
Despite the fact that the precise targeted chromatin incorporation mechanisms are still not
known for a lot of histone variants, the so far identified complex processes and multitude of
chaperones lead to the speculation that there might be one or several special histone chaper-
ones for the deposition of each variant.
1.3.6 Evolution of histone variants
Histones, especially H3 and H4, are among the most conserved proteins in the eukaryotic
genome. Nevertheless, a whole range of variants with quite specific functions have evolved.
Two different models for the evolution of multigene families have been described: concerted
evolution and the birth-and-death model of evolution. In concerted evolution, for example
acting on rRNA genes, the members of the gene family are homogenized by interlocus gene re-
combination or gene conversion. In contrast, evolution by the birth-and-death model assumes,
that new genes are created by repeated gene duplication and that some of these genes remain
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in the genome for a long time whereas others are deleted or become nonfunctional. This mode
of evolution applies for instance to the family of immunoglobulins (Nei and Rooney, 2005).
Histone genes have long been thought to evolve through concerted evolution, however, this
would mean that synonymous (silent) and nonsynonymous mutations should occur at almost
the same frequency in these genes. In several studies, investigating the linker histone H1
(Eir´ın-Lo´pez et al., 2004) as well as all four core histone families (Piontkivska et al., 2002;
Rooney et al., 2002; Gonza´lez-Romero et al., 2008, 2010), it has now been shown that the
frequency of synonymous substitutions is much higher than that of nonsynonymous. This
observation speaks for an evolution of histone gene families driven by the birth-and-death
mechanism combined with a strong purifying selection on the protein level.
Regarding the diversification into multiple variants, the first idea would certainly be that the
respective non-specialized variant constitutes the ancestral form. However, two aspects speak
against this hypothesis: First, some of the specialized variants, such as H2A.X and H3.3, are,
in contrast to their canonical forms, universally expressed (Table 1.1). Second, it is difficult
to imagine that something like the conserved S-Q-E/D-Φ-motif of H2A.X (Φ=hydrophobic
residue, Fig. 1.4A) has appeared independently multiple times in evolution. Therefore, it
seems likely that these specialized but universal proteins constitute the ancestral histones
(Talbert and Henikoff, 2010).
1.4 Objective
Over the last 20 years, several novel histone variants of the mammalian H1, H2A and H2B fam-
ily (e.g. macroH2A (Pehrson and Fried, 1992) or H2BFWT (Churikov et al., 2004)) have been
described, but regarding H3, it was thought that with the identification of CENP-A (Palmer
et al., 1987) and tH3 (Trostle-Weige et al., 1984) the set of this particular histone family was
complete. However, searching the histone database (http://research.nhgri.nih.gov/histones/),
several putative histone H3 variant genes were listed, opening up the fascinating possibility
of a whole range of additional H3 proteins with unique functions. In my PhD thesis I was
aiming to characterize the most interesting candidate(s) of this list in terms of (A) expression
levels in different cell lines and tissues, (B) sub-cellular localization and (C) biological function.
21
2 Materials and Methods
2.1 Materials
2.1.1 Technical devices
Description Supplier
-20 ◦C Freezer Bosch, Liebherr
-80 ◦C Freezer GFL
4 ◦C Fridge Siemens, Liebherr
37 ◦C Incubator (bacteria) Memmert
37 ◦C Incubator (mammalian cells) Heraeus
Agarose gel chamber Repair shop of Adolf-Butenandt-Institute
Autoclave (Varioklav) H+P
2100 Bioanalyzer Agilent
Cell counter Casy Cell Counter, Innovatis
Centrifuges Heraeus Megafuge 2.0
Haereus Biofuge pico
Thermo/Heraeus Pico 17
Thermo Shandon Cytospin 4
Eppendorf Centrifuge 5810R
Hettich Rotina 46
Concentrator plus Eppendorf
Developer machine Curix 60 Agfa
Ettan microLC (HPLC) Amersham Pharmacia Biotech
Gel documentation system Peqlab
Hood CleanAir
HPLC C4 column
(250 x 4.6mm Jupiter 10µm 300 A˚) Phenomenex
Imaging system LI-COR
Incubation shaker (Multitron) Infors
LightCycler R©) 480 II Roche
LC Ultimate 3000 Dionex
LTQ Orbitrap XL Thermo
Microscopes DMIL LED (Leica)
Axiovert 200M (Zeiss)
LSM 510 META confocal (Zeiss)
LSM 710 confocal (Zeiss)
personalDV widefield epifluorescence
(Applied Precision)
UltraVIEW VoX spinning disc
(PerkinElmer)
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Description Supplier
Microscopes OMX DeltaVision prototype
(Applied Precision)
Microwave LG
MilliQ-water Millipore
Odyssey R© imaging system LI-COR
pH-meter inoLab pH 720
Pipetboy Integra Biosciences
Pipettes Gilson
Power supply BioRad
Proteingel chamber (Novex Mini Cell) Invitrogen
REPETMAN R© multistep pipet Gilson
Rotating wheel Neolab, VWR
RTCA DP Analyzer Roche
Scales Sartorius
Shaker Roth
Spectrophotometer Nanodrop ND1000, Peqlab
ThermalCycler 2720 Applied Biosystems
Thermomixer 5436 Eppendorf
Trans Blot R© SD Semi-dry transfer cell BioRad
UV Stratalinker 1800 Stratagene
Vortex Genie 2 R© Bachofer
Water bath Memmert
2.1.2 Chemicals and consumables
Unless otherwise stated, all common chemicals are purchased in analytical grade from Merck.
Description Supplier
1.5 ml and 2 ml reaction tubes Greiner, Sarstedt
15 ml and 50ml tubes Sarstedt
96-well plates Peqlab
Acetonitrile Roth
Agarose SeaKem R© ME Biozym
Ampicillin Roth
Aqua-Poly/Mount Polysciences
Bacto Agar BD
Bacto Tryptone BD
Cling film Saran
BSA 98% Sigma
Cellculture plates Sarstedt
Cellophan Roth
Combitips plus Eppendorf
Complete Protease Inhibitor Cocktail Tablets Roche
Coomassie Brilliant Blue R Sigma
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Description Supplier
Cover slips Roth
Cryovials Roth
DAPI Invitrogen
Developer Agfa
DMSO Sigma
DNA oligonucleotides Sigma
dNTP mix NEB
DTT Roth
Dulbecco’s Modified Eagle Medium (DMEM) Invitrogen (low glucose + GlutaMAX)
PAA (high glucose + L-glutamine)
Dynabeads R© M-280 Sheep anti-Mouse IgG Invitrogen
ECLTM Western Blotting Detection Reagents Amersham
EDTA Sigma
EGTA Sigma
Ethidium bromide Sigma
FCS dialyzed Sigma
Filter paper Whatman 3MM Whatman
Filter tips Sarstedt, Molecular BioProducts
Filter unit Nalgene 0.2 µm filter holes
Fixer Agfa
FuGENE HD Transfection Reagent Roche
G418-sulfate (TC) PAA
Glass pipettes 5 ml and 10 ml Hirschmann R©
Glassware Schott
Human Gene 1.0 ST Arrays Affymetrix
Human tissue sections (frozen) Biochain
IPTG Roth
Krebs-Ringer Bicarbonate Buffer Sigma
Laboratory film Parafilm R©
Lab-Tek chamber slides Nunc
LightCycler R© 480 Multiwell Plate 384, white Roche
LightCycler R© 480 Sealing Foil Roche
MaXtractTM High Density column Qiagen
β-Mercaptoethanol Sigma
McCoy’s 5A Medium Invitrogen
Microscope slides SuperFrost R© Roth
Multiply R©-µStripPro with 8 0.2ml tubes Sarstedt
Nocodazole Sigma
NP-40 Sigma
Oligofectamine R© Transfection Reagent Invitrogen
Omnifix R©-F syringes Braun
Opti-MEM R© I Reduced-Serum Medium Invitrogen
PAP pen Kisker
Pasteur pipettes Brand
24
Materials
Description Supplier
Penicillin / Streptomycin PAA
Peptides Proteomics Resource Center of
The Rockefeller University
Peptide Specialty Laboratories GmbH
Petridishes Greiner
Pipette tips Brand, Sarstedt
PMSF Sigma
Ponceau S solution Sigma
Propidium iodide Sigma
Protein gel cassettes (disposable) Invitrogen
Protran R© Nitrocellulose Transfer Membrane Whatman
PVDF Transfer Membrane HybondTM-P Amersham
Rotiphorese Acrylamide/bisacrylamide mix Roth
RPMI Medium 1640 Invitrogen
RTCA E-Plate 16 Roche
SDS Serva
siRNAs Eurofins MWG Operon
Sterican R© needles Braun
TEMED Roth
TFA Roth
To-Pro3 Invitrogen
Total RNA from human tissues Applied Biosystems (normal lung and
breast, tumor lung, breast and ovary)
Biochain (tumor lung, breast, thyroid
and bone, normal testis and brain)
Tris Invitrogen
Triton X-100 Sigma
Trypsin/EDTA (TC) PAA
Tween 20 Sigma
VECTASHIELD R© Mounting Medium Vector Laboratories
Water, PCR-grade Roche
X-ray films Fujifilm
Xylene cyanol Sigma
2.1.3 Kits, enzymes and markers
Description Supplier
100bp DNA marker NEB
1kb DNA marker NEB
DNA 1000 Kit Agilent
Gel extraction Kit Qiagen
LightCycler R© 480 SYBR Green I Master Roche
Maxi- and Midiprep Kit Qiagen, Promega
Micrococcal nuclease Sigma
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Description Supplier
PCR-purification Kit Qiagen
peqGOLD Protein Marker IV, V Peqlab
Phusion R© DNA Polymerase Finnzymes
Pfu Turbo DNA Polymerase Stratagene/Agilent
ProLong R© Antifade Kit Invitrogen
ProtoScript R© First Strand cDNA Synthesis Kit NEB
ProtoScript R© M-MuLV Taq RT-PCR Kit NEB
Restriction endocucleases NEB
RNA 6000 Nano Kit Agilent
RNase-Free DNase Set Qiagen
RNeasy Kit Qiagen
RNeasy MinElute Cleanup Kit Qiagen
Taq DNA Polymerase NEB
2.1.4 Antibodies
2.1.4.1 Primary antibodies
Name Supplier Application Dilution
rat αH3.X/Y (clone 8H6-2111) E. Kremmer WB 1:50
IF 1:20
mouse αHA (clone 12CA5) Roche WB 1:1000
IF 1:500
rabbit αH3S10ph Millipore IF 1:200
rabbit αH3 (C-terminus) Abcam WB 1:5000
mouse αNeuN Millipore IH 1:500
rabbit αGFAP Dako Cytomation IH 1:1000
2.1.4.2 Secondary antibodies
Name Supplier Application Dilution
αrat HRP Amersham WB 1:5000
αrabbit HRP Amersham WB 1:5000
αmouse IRDye700DX Rockland Licor 1:10000
αrabbit IRDye800DX Rockland Licor 1:10000
αrat Alexa 488 Invitrogen IF 1:2000
αmouse Alexa 488 Invitrogen IF 1:2000
αrabbit Rhodamine red X Dianova IF 1:1000
αrabbit Cy5 Dianova IH 1:250
αrat biotin Vector Laboratories IH 1:100
streptavidin Alexa 555 Dianova IH 1:500
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2.1.5 Plasmids
Name Source Description Marker
pT7Blue-3 Novagen used for subcloning Amp, Kan
pIRESneo3 HA Holger Dormann
expression of N-terminally
HA-tagged proteins in
mammalian cells
Amp, Neo
pIRESneo3 HA-H3.1 Clemens Bo¨nisch
pIRESneo3 HA-H3.2 Clemens Bo¨nisch
pIRESneo3 HA-H3.3 Clemens Bo¨nisch
pIRESneo3 HA-H3.X Clemens Bo¨nisch
pIRESneo3 HA-H3.Y this study
pEGFP-C1 Clontech
expression of N-terminally
GFP-tagged proteins in
mammalian cells
Kan, Neo
pEGFP-C1 H3.1 this study
pEGFP-C1 H3.2 this study
pEGFP-C1 H3.3 this study
pEGFP-C1 H3.X this study
pEGFP-C1 H3.Y this study
pET-21a(+) Novagen
expression of un-tagged
proteins in E. coli
Kan, NeopET-21a(+) H3.X this study
pET-21a(+) H3.Y this study
2.1.6 Oligonucleotides
For simplicity, oligonucleotides are listed in the appendix in Tables A.1 (Oligonucleotides for
qPCR), A.2 (Oligonucleotides for cloning) and A.3 (Oligonucleotides for RNAi).
2.1.7 Bacterial strains and cell lines
2.1.7.1 E. coli strains
Strain Genotype Supplier
DH5α F- Φ80dlacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1
hsdR17 (rK
-, mK
+) phoA supE44 λ- thi-1 gyrA96 relA1
(Hanahan, 1985)
Genentech
XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac
[F’proAB lacI qZ∆M15 Tn10 (Tetr)]
Stratagene
BL21-CodonPlus
(DE3)-RIL
B F- ompT hsdS(rB
-, mB
-) dcm+ Tetr gal λ (DE3) endA
Hte [argU ileY leuW Camr]
Stratagene
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2.1.7.2 Mammalian cell lines
Table 2.8. Mammalian cell lines
Cell line Organism Origin Source Medium
HeLa Homo sapiens cervical cancer ATCC (CCL-2)
DMEM + 10% FCS + 1% P/S
HeLa Kyoto Homo sapiens cervical cancer Heinrich Leonhardt
U2OS Homo sapiens osteosarcoma ATCC (HTB-96)
MG63 Homo sapiens osteosarcoma ATCC (CRL-1427)
HEK293 Homo sapiens transformed embryonic
kidney cells
ATCC (CRL-1573)
Rat Nb Rattus norvegicus neuroblastoma Marion Cremer
NIH3T3 Mus musculus fibroblasts ATCC (CRL-1658)
SAOS-2 Homo sapiens osteosarcoma ATCC (HTB-85) McCoy’s + 15% FCS + 1% P/S
Raji Homo sapiens B-cell ATCC (CCL-86) RPMI + 10% FCS + 1% P/S
Primary fibroblasts Homo sapiens skin derived Marion Cremer
DMEM 20% FCS + 1% P/S
Primary fibroblasts Pan paniscus skin derived Stefan Mu¨ller
Primary fibroblasts Macaca nemestrina skin derived Stefan Mu¨ller
Primary fibroblasts Callithrix jacchus skin derived Stefan Mu¨ller
Primary fibroblasts Eulemur fulvus skin derived Stefan Mu¨ller
Table 2.9. Stably transfected mammalian cell lines
Cell line Organism Plasmid Source Medium
HeLa empty vector Homo sapiens empty pIRESneo3 HA this study
DMEM + 10% FCS + 1% P/S
+ 400µg/ml G418-sulfate
HeLa HA-H3.1 Homo sapiens pIRESneo3 HA-H3.1 Clemens Bo¨nisch
HeLa HA-H3.3 Homo sapiens pIRESneo3 HA-H3.3 Clemens Bo¨nisch
HeLa HA-H3.X Homo sapiens pIRESneo3 HA-H3.X this study
HeLa HA-H3.Y Homo sapiens pIRESneo3 HA-H3.Y this study
U2OS empty vector Homo sapiens empty pIRESneo3 HA this study
U2OS HA-H3.X Homo sapiens pIRESneo3 HA-H3.X this study
U2OS HA-H3.Y Homo sapiens pIRESneo3 HA-H3.Y this study
Fetal calf serum (FCS) was inactivated by incubation for 20min at 56 ◦C in a water bath. Unless stated otherwise, DMEM from PAA was used.
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2.1.8 Software
Device/Application Software
Licor Odyssey 2.1 (LI-COR)
Image processing Adobe Photoshop
AxioVision (Zeiss)
Image J
LSM 510 META (Zeiss)
Zen 2009 (Zeiss)
In silico modeling I-Tasser server
Microarray data analysis R/Bioconductor (www.bioconductor.org)
Orbitrap Mascot (Matrix Science)
Phylogeny analysis MacVector
Primer design Primer3 0.4.0 (Rozen and Skaletsky, 2000)
qPCR LightCycler R© 480 SW 1.5 (Roche)
RP-HPLC Unicorn 5.11 (GE)
RTCA DP Analyzer RTCA Software 1.2.0.0909
Visualization of protein structures Swiss-Pdb-Viewer
(Guex and Peitsch, 1997)
PyMOL (DeLano Scientific LLC)
Sequence alignments MacVector 10.0.2
2.2 Buffers and solutions
Ampicillin stock solution 100mg/ml Ampicillin (1000x)
Buffer A (Mononucleosomes) 10mM HEPES (pH7.9)
10mM KCl
1.5mM MgCl2
0.34M Sucrose
10% Glycerol (v/v)
1mM DTT
Complete Protease Inhibitor Cocktail
Buffer C (Mononucleosomes) 20mM HEPES (pH7.9)
20% Glycerol (v/v)
0.2mM EDTA
0.2% Triton X-100 (v/v)
300mM KCl
Complete Protease Inhibitor Cocktail
Chloramphenicol stock solution 34mg/ml Chloramphenicol in ethanol (2000x)
Coomassie destaining solution 10% Glacial acetic acid (v/v)
30% Methanol (v/v)
Coomassie staining solution 10% Glacial acetic acid (v/v)
50% Methanol (v/v)
0.1% Coomassie Brilliant Blue R (w/v)
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6x DNA loading buffer 0.25% Bromophenol blue (w/v)
0.25% Xylene Cyanol (w/v)
30% Glycerol (v/v)
Ethidium bromide stock solution 10mg/ml Ethidium bromide (20000x)
Hypotonic lysis buffer 10mM Tris (pH 8.0)
1mM KCl
1.5mM MgCl2
Complete Protease Inhibitor Cocktail
1mM DTT
0.4mM PMSF
Kanamycin stock solution 10mg/ml Kanamycin (1000x)
10x KCM buffer 1.2M KCl
200mM NaCl
100mM Tris (pH 8.0)
5mM EDTA
5x Laemmli loading buffer 314mM Tris
50% Glycerol (v/v)
5% SDS (v/v)
5% β-Mercaptoethanol (v/v)
0.01% Bromophenol blue (w/v)
adjust pH to 6.8 with HCl, store aliquots at -20 ◦C
Laemmli running buffer 25mM Tris
192mM Glycine
0.1% SDS (w/v)
LB agar plates LB medium
1.5% Bacto agar (w/v)
LB medium 1.0% Tryptone (w/v)
0.5% Yeast extract (w/v)
1.0% NaCl (w/v)
Low-HEPES buffer 4mM HEPES (pH7.9)
10mM NaCl
No-salt buffer 3mM EDTA
0.2mM EGTA
PBS buffer 140mM NaCl
2.7mM KCl
10mM Na2HPO4
1.8mM KH2PO4
RBS buffer 10mM Tris (pH 7.5)
10mM NaCl
5mM MgCl2
Separating gel 15% Acrylamide
0.4% Bis-acrylamide
363mM Tris (pH 8.8)
0.1% SDS (w/v)
0.1% TEMED (v/v)
0.1% Ammonium persulfate (w/v)
Solvent A (HPLC) 0.1% TFA (v/v)
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Solvent B (HPLC) 99.92% Acetonitrile (v/v)
0.08% TFA (v/v)
Stacking gel 4% Acrylamide
0.1% Bis-acrylamide
125mM Tris (pH 6.6)
0.1% SDS (w/v)
0.1% TEMED (v/v)
0.1% Ammonium persulfate (w/v)
TBE buffer 45mM Tris
45mM Boric acid
1mM EDTA
TBS buffer 32mM NaCl
10mM Tris (pH 7.5)
Transfer buffer 48mM Tris
39mM Glycine
0.0375% SDS (w/v)
20% Methanol (v/v)
Wash buffer (mononucleosomes) 20mM HEPES (pH7.9)
20% Glycerol (v/v)
0.2mM EDTA
0.2% Triton X-100
300mM KCl
Complete Protease Inhibitor Cocktail
2.3 Cell biological methods
2.3.1 Cultivation and manipulation of mammalian cells
2.3.1.1 Cultivation of mammalian cells
All mammalian cell lines used in this work (see Tables 2.8 and 2.9) were kept in their re-
spective media in a 37 ◦C incubator with a humidified atmosphere of 5% CO2. For details
regarding media composition see Tables 2.8 and 2.9.
Cells were split every 2 to 3 days in a ratio between 1:2 and 1:8 depending on the doubling
time of the cell line. Suspension cells (Raji): Cell suspension was partially discarded and
replaced by fresh medium. Semi-adherent cells (HEK293): Cells were washed from the plate
with the medium covering the cells, cell suspension was partially discarded and replaced by
fresh medium. Adherent cells (fibroblasts, HeLa, osteosarcoma and neuroblastoma cells):
Medium was removed, cells were washed once with sterile PBS and trypsin/EDTA-solution
(1:8-diluted in sterile PBS) was added. Detached cells were resuspended in fresh growth
medium, cell suspension partially discarded and replaced by fresh medium.
When harvesting cells for further experiments, cells were counted using a Casy cell counter,
pelleted by gentle centrifugation (310 g, 10min) and washed once with PBS.
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For storage, cells were resuspended in FCS + 10% DMSO, transferred to cryo vials and frozen
at -80 ◦C. For long term storage, frozen vials were kept in liquid nitrogen. Cells in culture
were replaced every 2 to 3 months. A fresh vial was thawed quickly in a 37 ◦C water bath,
cells were pelleted by gentle centrifugation, DMSO containing FCS was removed and cells
were cultured as usual.
2.3.1.2 Cultivation of U2OS cells under different stress conditions
In order to identify the factor and/or condition that triggers H3.X/Y expression in U2OS
cells, different stress treatments were tested.
Starvation and Overgrowth (SO): 1 · 106 cells were seeded in a 10 cm plate with 7ml
medium. Cells were incubated over 8 days without splitting or replacement of medium.
Overgrowth: Cells were seeded identical to SO treatment and incubated over 8 days without
splitting but with replacement of medium every day.
Starvation: 1.5 · 106 cells were seeded in a 15 cm plate with 12ml medium. Cells were kept at
40-60% confluency by splitting, however, old medium was added back to the cells afterwards.
UV-treatment: Normally grown cells were treated with 25000µJ/cm2, 50000µJ/cm2 or
100000µJ/cm2 UV light using a Stratalinker 1800 followed by 3 h incubation at 37 ◦C.
Amino acid depletion: Normally grown cells were incubated for up to 9 h in Krebs-Ringer
Bicarbonate Buffer, a medium lacking amino acids.
Serum depletion: Normally grown cells were incubated for up to 12 h in DMEM containing
0.1%, 0.5%, 1%, 1.5%, 2% or 10% FCS.
2.3.1.3 Establishment of stably transfected human cell lines
Cells were seeded in 6-well plates 24 h prior to transfection to reach a confluency of 80-90%.
1µg plasmid DNA was diluted with Opti-MEM to a final volume of 100µl, 3µl FuGENE
HD reagent were added and the transfection complex was allowed to form over 15min at
room temperature (RT). The complex was added drop-wise to the cells while shaking the
plate. After 24 h incubation at 37 ◦C, medium was exchanged by selection medium (DMEM
+ 10% FCS + 1% P/S + 600µg/ml G418-sulfate) to select for stable cell lines. Selection was
carried out until cells in non-transfected control wells had died. Stable cell lines were grown
in medium supplemented with 400µg/ml G418-sulfate.
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2.3.1.4 mRNA knockdown using small interfering RNAs (siRNAs)
HeLa, HeLa HA-H3.X, HeLa HA-H3.Y and U2OS cells were transfected with siRNAs to
specifically reduce H3.X and/or H3.Y mRNA levels (for siRNA sequences see Table A.3).
Transfections were performed using Oligofectamine transfection reagent according to the man-
ufacturer’s instructions. In brief: Cells were seeded 24 h prior to transfection for a confluency
of 30%. Plate size was chosen depending on the number of cells needed for subsequent anal-
yses (for volumes used for different plates, see table below). For solution (A), Oligofectamine
was diluted in Opti-MEM. For solution (B), siRNA stock solution (100µM in 1x Universal
Buffer) was first diluted 1:5 in sterile MilliQ-water and then further 1:8.5 in Opti-MEM. Af-
ter 5min incubation at RT, solutions (A) and (B) were mixed and the transfection complex
was allowed to form over another 20min period at RT. Cells were washed twice with sterile
PBS, growth medium was replaced by DMEM (Invitrogen) not supplemented with serum or
antibiotics and the transfection complex was added. After 5 h incubation at 37 ◦C, DMEM
(Invitrogen) supplemented with 30% FCS but without antibiotics was added. The next day,
medium was replaced with normal growth medium (Invitrogen). Cells were harvested 4 days
after transfection. As U2OS cells are difficult to transfect, a double-knockdown on two con-
secutive days was performed. Cells were harvested 4 days after the first transfection.
Solution (A) Solution (B) Medium
DMEM +
Plate Oligofectamine Opti-MEM siRNA(20µM) Opti-MEM DMEM 30% FCS
12-well 3µl 7µl 5µl 85µl 400µl 250µl
6-well 4µl 11µl 10µl 75µl 800µl 500µl
10 cm 20µl 55µl 50µl 375µl 5ml 2.5ml
2.3.2 Proliferation analysis of adherent human cells
Proliferation capacity of adherent human cells was analyzed using two different methods:
CASY Counter: 2 · 105 cells were seeded in 6-well plates (3 wells per cell line and condi-
tion) and either transfected with siRNAs the following day or used directly for analysis of
proliferation capacity. Cells were trypsinized and counted every day using the CASY Counter,
cell number was adjusted to keep a confluency of 50-70% and mean of cell count in 3 wells
was plotted.
RTCA DP Analyzer equipped with 16-well E-plates: Baseline was set using 100µl
medium (Invitrogen) per well, 4500 cells in 50µl medium were added (4 wells for each cell line
and experimental condition) and measurement was started after 30min incubation at RT dur-
ing which cells sink to the bottom of the well and start to adhere. Impedance was measured
every 15min over 96 h, providing quantitative information about the biological status of the
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cells, including cell number, viability, and morphology. Growth medium was replaced every
day. If siRNA-treated cells were analyzed, cells were seeded one day after the last siRNA
transfection.
2.3.3 Antibody generation and specificity testing
The antibody against H3.X and H3.Y (αH3.X/Y) was generated by our collaborator Elis-
abeth Kremmer using a peptide spanning amino acids 9 to 20 of histone H3.X and H3.Y
(KATAWQAPRKLP, Peptide Specialty Laboratories GmbH). The peptide was coupled to
BSA and ovalbumin (OVA), respectively, and rats were immunized subcutaneously and in-
traperitoneally with a mixture of 50µg peptide-OVA, 5 nmol CPG oligonucleotide (Tib Mol-
biol), 500µl PBS and 500µl incomplete Freund’s adjuvant. Six weeks later, a boost without
adjuvant was given. Fusion was performed according to standard procedures (Ko¨hler and
Milstein, 1975). Supernatants were tested by differential enzyme-linked immunosorbent assay
(ELISA) with the histone peptide and an irrelevant peptide, both coupled to BSA. Mono-
clonal antibodies reacting specifically with the peptide were further analysed in Western blot
and immunofluorescence (IF) microscopy. αH3.X/Y clone 8H6-2111 of rat IgG2a subclass
was deployed in this study.
αH3.X/Y specificity was analyzed by peptide competition assay with subsequent IF analysis
(see section 2.3.4). Prior addition to the cells, the antibody (diluted in blocking solution) was
incubated for 4 h at 4 ◦C with the following peptides (1µg/ml): biotin-coupled H3.3 unmod-
ified (aa 22 - 41) and H3.X/Y unmodified (aa 9 - 20). Samples were analyzed on an Axiovert
200M microscope.
2.3.4 Immunofluorescence (IF) microscopy
Adherent mammalian cells were grown and stained on 12mm cover slips in 24-well plates.
In brief, cells were washed with PBS, fixed for 15min in 1% formaldehyde-PBS, permeabi-
lized in PBS-T (PBS + 0.1% Triton X-100) and blocked for 20min in PBS-T + 1% BSA.
Samples were incubated stepwise with primary and secondary antibody (diluted in blocking
solution) for 30min with three consecutive 5min PBS-T washes. For details about antibodies
and dilutions see sections 2.1.4.1 and 2.1.4.2. DNA was stained for 5min with 10 ng/ml 4’,6-
diamidino-2-phenylindole (DAPI) in PBS and mounted with ProLong Antifade Kit. Samples
were analyzed using an Axiovert 200M microscope.
To determine percentage of cells with general nuclear αH3.X/Y staining, positive cells were
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counted and representative pictures of the sample, showing the cell density on the cover slip,
were taken. Percentage of positive cells was calculated by dividing the number of positive
cells by the average cell number per picture multiplied with the number of pictures per cover
slip.
For analysis on a LSM 510 META confocal microscope, DNA was counter stained using To-
Pro3 and samples were mounted using Vectashield mounting medium.
Samples for 3D-SIM analysis were prepared on precision cover glass #1.5 (0.170±0.005mm
thick; Roth) and embedded in Vectashield mounting medium. Sample preparation and analy-
sis on an OMX DeltaVision prototype was performed by our collaborator Lothar Schermelleh
(Advanced Cell Imaging Unit, LMU Munich).
2.3.5 Metaphase chromosome spreads
Metaphase chromosome spreads of adherent human cells were generated as previously de-
scribed (Hake et al., 2005). In short, cells were arrested in mitosis by a 15 -16 h treatment
with nocodazole (transfected HeLa cells: 200 ng/ml; U2OS cells: 1µg/ml), harvested by
mitotic shake-off, lysed by incubation in RBS buffer and spread on microscope slides by
centrifugation in a Shandon Cytospin 4. Cells were fixed in 2% formaldehyde in PBS and
washed with KCM-Tween (1xKCM + 0.1% Tween 20). Chromosomes were extracted with
KCM-Tween + 0.1% Triton X-100, washed with KCM-Tween and KCM-Tween-BSA (KCM-
Tween + 0.25% BSA), blocked in KCM-Tween + 2.5% BSA and incubated with primary
antibody in blocking solution overnight (ON) at 4◦C. After washing with KCM-Tween-BSA,
chromosomes were incubated with secondary antibody in blocking solution for 1-2 h at RT
and washed with KCM-Tween and PBS + 0.1% Tween 20. DNA was stained with 10 ng/ml
DAPI for 5min, samples were washed with PBS and mounted with Vectashield mounting
medium. Except for washes, microscope slides were incubated in an opaque wet chamber.
Analysis was carried out with a personalDV widefield epifluorescence microscope followed by
a deconvolution procedure.
2.3.6 Fluorescence recovery after photobleaching (FRAP)
FRAP analyses were performed by our collaborator Lothar Schermelleh (Advanced Cell Imag-
ing Unit, LMU Munich). HeLa Kyoto cells were transiently transfected with GFP-tagged
histone H3 constructs (see section 2.1.5). After 24 h, cells were seeded in Lab-Tek chamber
slides and incubated several hours or ON before performing FRAP experiments. FRAP rates
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were determined using an UltraVIEW VoX spinning disc microscope with integrated FRAP
PhotoKinesis accessory assembled to an Axio Observer D1 inverted stand (Zeiss). The mi-
croscope’s heated environmental chamber was set to 37 ◦C and 5% CO2 perfusion. Several
square bleach regions with a size of 5 x 5µm were positioned on selected cell nuclei within
the field of view. Photobleaching was performed using two iterations with the Acousto Optic
Tunable Filter (AOTF) of the 488 nm and the 514 nm laser line set to 100% transmission.
To determine long-term recovery kinetics, 3D image stacks of 8µm height and a z-distance
between image planes of 1µm were recorded with an initial speed of 1 f/min for the first 10
frames, followed by intervals of 10min. Using ImageJ, raw data were corrected for lateral
and rotational movements of the nucleus, differences in background and gain or loss of total
fluorescence during postbleach acquisition, potentially caused by newly synthesized GFP-
histones, bleaching-by-acquisition and flux of residual fluorescence from above and below the
recorded optical plane. To correct for cell-to-cell differences in bleaching depth, the data were
normalized to zero by subtracting the first postbleach value from all mean fluorescence values.
2.3.7 Immunohistochemistry (IH) microscopy
Commercially available human tissue sections were stained in an opaque wet chamber at RT
unless stated otherwise. Frozen sections were thawed and blocked in PBS + 0.5% Triton
X-100 + 0.5% BSA for 30min. Samples were incubated with primary antibody in block-
ing solution ON at 4 ◦C followed by three 10min PBS-washes. Incubation with secondary
antibody in blocking solution was carried out for 2h followed by three 10min PBS-washes.
To enhance H3.X/Y signals, biotin-coupled secondary αrat antibody was used followed by
a 2 h incubation with streptavidin coupled to an Alexa 555 fluorophor diluted in PBS. DNA
was counter stained for 5min with 1µg/ml DAPI in PBS and samples were mounted using
Aqua-Poly/Mount. Analysis was carried out on a LSM 710 confocal microscope.
2.4 Molecular biological methods
2.4.1 Agarose gel electrophoresis
DNA fragments were separated using 1% agarose gels prepared with TBE buffer. To visualize
DNA fragments, ethidium bromide was added to the gel at a final concentration of 0.5µg/ml.
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2.4.2 RNA extraction of mammalian cells
Total RNA from 1-2 · 106 cells was extracted using the RNeasy Kit following the manufac-
turer’s instructions, including removal of genomic DNA contaminations. RNA concentration
and purity was determined using a Nanodrop ND1000 spectrophotometer, RNA was stored
at -80 ◦C.
2.4.3 RNA expression profiling
Microarry hybridization was performed by Dietmar Martin and Kerstin Maier of the Gene
Center Affymetrix Microarray Platform (Cramer Laboratory, LMU Munich). Bioinformatical
analysis was carried out by Tobias Straub (Becker Laboratory, LMU Munich). Concentra-
tion and quality of total RNA preparations (see section 2.4.2) were evaluated using the RNA
6000 Nano Kit and the 2100 Bioanalyzer. 100 ng of RNA were further purified with the
RNeasy MinElute Cleanup Kit and RNA amplification, labeling and hybridization to Hu-
man Gene 1.0 ST Arrays were performed according to the manufacturer’s instructions. Raw
microarray data were processed in R/Bioconductor as follows: gene-based expression values
were calculated using the Robust Multichip Average (RMA) method as part of the ’oligo’
package. For downstream analyses, genes with a log2 expression value of at least 4 in at
least one of the treatment conditions were used. Differential expression estimation was based
on a moderated t statistic (’limma’ package) with subsequent calculation of the local false
discovery rate (lfdr, ’locfdr’ package). Genes were classified as responders by a lfdr cutoff
of 0.2. Gene ontology enrichment analysis was performed using a hypergeometric distribu-
tion test and subsequent Bonferroni correction as supplied by the GOHyperGALL script
(http://faculty.ucr.edu/∼tgirke/Documents/R BioCond/My R Scripts/GOHyperGAll.txt).
Term redundancy was reduced by applying the GOHyperGAll Simplfy function with a p-value
cutoff of 0.001. The microarray data for siRNA transfected U2OS cells has been deposited at
GEO (www.ncbi.nlm.nih.gov/geo) under the accession number GSE22415.
2.4.4 cDNA synthesis
cDNA was first synthesized using the ProtoScript First Strand cDNA Synthesis Kit and later
the ProtoScript M-MuLV Taq RT-PCR Kit due to discontinuation of the first product. cDNA
was transcribed from 1µg of total RNA (see section 2.4.2) per reaction, following the instruc-
tions given in the protocol using random primers. Samples without reverse transcriptase (no
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RevT) were processed in parallel to control for genomic DNA contamination. PCR ampli-
fication of a GAPDH-mRNA fragment with Taq polymerase and subsequent analysis on an
agarose gel was taken as a readout for successful cDNA synthesis (for primer sequences see
Table A.1).
2.4.5 Quantification of mRNA levels with quantitative PCR (qPCR)
mRNA levels of genes of interest were quantified relative to mRNA levels of stably expressed
reference genes with qPCR using a LightCycler 480 II equipped with a 384-well block. Primer
pairs were designed using Primer3 software (Rozen and Skaletsky, 2000), qPCR primers are
listed in Table A.1. Samples were analyzed in technical triplicates for each primer pair with
a total volume of 15µl per well. For each reaction 0.75µl cDNA (see section 2.4.4) were
diluted to 5µl with PCR-grade water and distributed to different wells using a multistep
pipet and 0.1ml combitips. In a second step 7.5µl LightCycler 480 SYBR Green I Master
mix (2x) were mixed with primers and PCR-grade water to a volume of 10µl with each
primer in a concentration of 0.44µM. SYBR/primer mix was distributed to different wells
using a multistep pipet and 0.2ml combitips. Plate was sealed with adhesive foil, centrifuged
for 2min at 3000 g and qPCR was performed with temperature profile summarized below.
Experiments were analyzed using the advanced relative quantification tool of LightCycler
480 SW 1.5 software, factoring in differences in primer efficiency (see below) and calculating
mRNA levels relative to a combination of two reference genes (HPRT1 and HMBS ). Samples
with no RevT cDNA (see section 2.4.4) were used to quantify background levels caused by
genomic DNA contamination.
Primer pairs were tested for specificity and efficiency by using non template controls, melting
curves and dilution series of cDNA. To calculate primer efficiencies and determine primer
specific detection threshold, a dilution series of cDNA, generated from a mix of HeLa HA-
H3.X and -H3.Y cells, was used. Standard curves were analyzed using the advanced absolute
quantification tool of LightCycler 480 SW 1.5 software.
Pre-Incubation 5min 95 ◦C
10 s 95 ◦C
45x Amplification 10 s 60 ◦C
10 s 72 ◦C
5 s 95 ◦C
Melting Curve 1min 65 ◦C
2.5 ◦C/min 97 ◦C
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2.4.6 Cloning of mammalian H3 variants
Histone H3 variants were amplified from human cDNA (see section 2.4.4) using gene specific
primers flanked by restriction endonuclease recognition sites (for primer sequences see Table
A.2) and Phusion DNA polymerase. PCR-products were subcloned with EcoRV in pT7Blue-3
vector, leading to a disruption of the LacZ gene, thereby enabling selection of positive clones
over blue/white screening. Subcloning reaction was transformed in chemically competent
E. coli (XL1 Blue or DH5α) with a heat shock of 45 s at 42 ◦C. After 1 h incubation in LB
medium at 37 ◦C, cells were plated on LB agar plates containing the respective antibiotic
(ampicillin 100µg/ml or kanamycin 10µg/ml). Plasmid DNA was isolated using a miniprep
kit. H3 variant cDNA was excised with the respective restriction endonucleases, fragments
were gel purified using a gel extraction kit and ligated with the vector backbone which has
been cut and purified in the same way. Ligation reaction was transformed in chemically com-
petent XL1 Blue or DH5α as described above. Cloning success was verified by sequencing
(Eurofins MWG Operon) of isolated and purified plasmids.
2.4.7 Site directed mutagenesis of H3.Y
To perform RNAi rescue experiments, siRNA target regions in H3.Y (as part of pIRES-
neo3 HA) were mutated without changing the amino acid sequence. Mutagenesis was per-
formed using Pfu DNA polymerase, following the manual for the Stratagene (Agilent) site-
directed mutagenesis kit. Briefly, pIRESneo3 HA-H3.Y was amplified using primers carrying
the desired mutation (see Table A.2), template plasmid was digested with DpnI and PCR-
reaction was transformed in chemically competent E. coli. Plasmid DNA was isolated with a
miniprep kit, sequenced and used to establish stable cell lines (see section 2.3.1.3).
2.4.8 Expression of human histone proteins in E. coli
E. coli expression strain BL21-CodonPlus (DE3)-RIL was transformed with pET-21a(+) H3.X
and H3.Y plasmids as descibed in section 2.4.6. Transformed E. coli were grown in LB medium
supplemented with kanamycin (10µg/ml) and chloramphenicol (17µg/ml). Expression was
induced in an exponentially growing culture for 3 h at 37 ◦C by adding IPTG to a final concen-
tration of 0.1mM. Cells were harvested and boiled for 10min at 95 ◦C in 1x Laemmli loading
buffer. Cell debris was removed by centrifugation and supernatant was used for Western blot
analysis.
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2.5 Biochemical methods
2.5.1 Histone extraction from mammalian cells
Histones were acid extracted as previously described (Shechter et al., 2007). In short, nuclei
were isolated using hypotonic lysis buffer and extracted with 0.4 M sulfuric acid. Histones
were precipitated with 100% trichloroacetic acid and resuspended in water.
2.5.2 Reversed phase-high performance liquid chromatography (RP-HPLC)
of mammalian histones
Acid extracted histones (see section 2.5.1) from U2OS, HEK293 and NIH3T3 were separated
on an Ettan microLC over a C4 column (250 x 4.6 mm Jupiter 10 µm 300 A˚) using a linear
gradient from 35% to 53% solvent B with a flow of 1.0ml/min over 30min. Fractions of
200µl were collected, vacuum dried and stored at -20 ◦C. Fractions containing H3.X and/or
H3.Y protein were identified using Western blotting (see section 2.5.8) and analyzed using
mass spectrometry (see section 2.5.3).
2.5.3 Mass spectrometrical analysis of HPLC-purified mammalian histones
Mass spectrometrical analysis was performed by our collaborator Lars Israel (LMU Munich,
Protein Analysis Unit). In brief, RP-HPLC fractions containing H3.X and/or H3.Y (see
section 2.5.2) were resolved in 0.1M ammonium bicarbonate and treated with propionic an-
hydride to convert free amino groups of lysine residues to propionic amides, thereby preventing
digestion after lysines. Proteolytic digestion with sequencing grade trypsin (Promega) was
carried out ON at 37 ◦C and samples were directly loaded onto a nano-ESI-LC-MS/MS for
protein identification. The resulting data where analyzed via Mascot software using a home-
made database containing the diverse H3 sequences. Fragment spectra were also interpreted
manually.
2.5.4 Mononucleosome immunoprecipitation (IP)
Mononucleosome IP was performed by Clemens Bo¨nisch, PhD student in the Hake group.
Mononucleosomes were generated, with some changes, as previously described (Wysocka et al.,
2001). All centrifugation steps prior to Micrococcal Nuclease (MNase) treament were per-
formed at 3200 g at 4 ◦C. Briefly, aliquots of 2 · 107 cells were lysed in buffer A + 0.1% NP-40,
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washed with buffer A and and incubated in buffer B. Mononucleosomes were generated by
digestion of chromatin with 0.25U MNase for 15min at 37 ◦C in buffer A + 1mM CaCl2 and
stopped by addition of EGTA (final concentration 2mM). Un-digested material was removed
by centrifugation (20000 g for 20min), supernatants of five MNase digests were combined and
salt concentration was adjusted to 150mM KCl. Monoclonal mouse αHA was immobilized
on magnetic beads (sheep αmouse IgG) and IP was performed ON. Beads were washed four
times with buffer C and bound mononucleosomes were eluted with 100mM glycine (pH2.8).
One part of these beads was used to isolate DNA with phenol/chloroform extraction using
MaXtract High Density columns followed by sodium acetate/ethanol precipitation. DNA size
and quality was evaluated using the DNA 1000 kit with the 2100 Bioanalyzer. From the rest
of the beads, bound proteins were eluted by boiling in SDS sample buffer and subsequently
analyzed by Western blotting using Licor detection (see section 2.5.8) and silver staining (see
section 2.5.7).
2.5.5 SDS polyacrylamide gel electrophoresis (SDS-PAGE)
Proteins were separated using 15% separating polyacrylamide gels covered by stacking gels us-
ing disposable cassettes and 10-, 12- or 15-well combs. Gels were run at 100V until prestained
size marker (peqGOLD Protein Marker IV or V) started to separate. Run was continued at
180V until loading dye reached end of the gel. Subsequently, gels were stained with Coomassie
Blue (see section 2.5.6) or silver nitrate (see section 2.5.7) or used for Western blotting (see
section 2.5.8).
2.5.6 Coomassie staining of polyacrylamide gels
Polyacrylamide gels (see section 2.5.5) were incubated for 1 h in Coomassie staining solution,
followed by incubation in Coomassie destaining solution until background staining was re-
duced enough for protein bands to become visible.
2.5.7 Silver staining of polyacrylamide gels
Polyacrylamide gels (see section 2.5.5) were fixed in 40% ethanol (v/v) + 10% glacial acid
(v/v) ON or used directly after Coomassie staining (see section 2.5.6). Gels were washed in
50% methanol and water for 10min, respectively, followed by a 1min incubation in 0.02%
sodium thiosulfate (w/v) and two 1min washing steps in water. To stain protein bands,
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gels were incubated in 0.1% silver nitrate (w/v) for 20min, rinsed twice with water (1min
each) and developed in 0.04% formaldehyde (v/v) in 2% sodium carbonate (w/v) with vig-
orous shaking. To terminate development when protein bands become visible, formalde-
hyde / sodium carbonate solution was discarded and replaced by 1% acetic acid.
2.5.8 Western blotting
Polyacrylamide gels were blotted on PVDF (ECL detection) or nitrcellulose (Licor detec-
tion) membranes using a semi-dry blotting machine. Gel and membrane were equilibrated
for 10min in transfer buffer (PVDF membrane was activated in methanol for 30 s prior to
equilibration) and blot was assembled by stacking two 3mmWhatman papers soaked in trans-
fer buffer, membrane, gel, and two more soaked 3mm Whatman papers. Air bubbles were
removed and proteins were transferred to the membrane over 1 h with 200mA. Membrane
was stained with Ponceau S solution and scanned to monitor protein loading. Membrane
was blocked for 1 h in TBS + 0.1% Tween 20 (TBS-T) + 5% milk powder (TBS-T milk,
ECL detection) or TBS + 5% milk powder (Licor detection) and incubated ON at 4 ◦C with
primary antibody diluted in TBS-T milk (for dilutions see section 2.1.4.1). Membrane was
washed three times with TBS-T, incubated for 1 h at RT (Licor detection: light protected)
with secondary antibody diluted in TBS-T milk (for dilutions see section 2.1.4.2) and washed
again three times with TBS-T. Membrane was either covered with ECL detection reagent,
followed by film exposure and development or scanned with the Licor machine.
2.6 Bioinformatics
2.6.1 Phylogenetic analysis of histone variants
The phylogenetic tree depicted in Fig. 3.2 was generated using coding nucleotide sequences
of different histone variants from human (Hs), chimpanzee (Pt) and macaque (Mm). Se-
quences were aligned using ClustalW Alignment (MacVector 10.0.2) and evolutionary rela-
tionships were determined using the neighborjoining tree-building method based on Kimura
2-parameter with Gamma correction off.
Changes in program parameters and/or inclusion of 3’ UTRs as well as analysis of 3’ UTRs
alone led to virtually the same result. The only difference was that H3.X and H3.Y were
either closer to H3.3A or H3.3B.
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2.6.2 In silico modeling of novel histone variants
To generate homology models for H3.X and H3.Y proteins, the I-TASSER server (Zhang,
2008) was used. It provides a combination of threading, assembly and refinement to generate
3D-models. As template, the server automatically chose for both novel variants chain A (hi-
stone H3.2) of pdb-file 1kx5. This structure resembles a nucleosome consisting of 147 bp of
Homo sapiens DNA wrapped around Xenopus laevis histones (Davey et al., 2002). The model
for H3.X had a C-score of 0.07, the model for H3.Y a C-score of 1.50. In both cases, C-score
for the second best model was considerably lower. Data-sets of the models were downloaded
and visualized using Swiss-Pdb-Viewer and PyMOL.
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3.1 Identification of novel histone H3 variant genes
Searching the NCBI database with the nucleotide sequence of human histone H3.1f
(HIST1H3I; NM 003533), two putative histone H3 variant genes have been found, now termed
H3.X (LOC340096) and H3.Y (LOC391769) (Fig. A.1, Appendix). Both genes were initially
annotated as pseudogenes, are located on human chromosome 5 (5p15.1) and do not contain
introns. Their sequence around the translation initiation start site matches the consensus for
vertebrates (GCCGCCACCAUGGCG) (Kozak, 1991; Nakagawa et al., 2008), and depending
on the search program used (polyadq or PolyA SVM program), H3.X and H3.Y 3’-genomic
sequences are predicted to include a conserved poly(A) site (Cheng et al., 2006; Tabaska and
Zhang, 1999).
H3.X and H3.Y genes are predicted to encode for highly similar proteins of 146 and 135
amino acids, respectively, with only four amino acids difference in their overlapping region
(89.7% identity) (Fig. 3.1). H3.X has an additional unusual C-terminal tail with no sequence
homology to other proteins. Both putative proteins display interesting sequence differences
compared to H3.1, H3.2 and H3.3, thereby generating potential new PTM sites or eliminating
amino acids known to be posttranslationally modified. One example is the replacement of ser-
ine 10 and 28, phosphorylated during mitosis (Hendzel et al., 1997) and immediate-early gene
induction (Clayton and Mahadevan, 2003), by alanine and arginine, respectively. In addition
to these single amino acid changes, also complete stretches appear to be altered. The most
prominently changed regions include the sequence surrounding lysine 14, usually acetylated
and found in actively transcribed genes (Yan and Boyd, 2006), and the region around lysine
79, which is found to be methylated in transcriptionally active regions (Im et al., 2003) and
upon DNA damage (Huyen et al., 2004) (Fig. 3.1). The sequence from amino acid 87 to 90 is
important for the chaperone-dependent chromatin incorporation of histone variants (Ahmad
and Henikoff, 2002). CAF-1 deposits H3.1, whereas HIRA and the Daxx-ATRX complex
catalyze the incorporation of H3.3 (Tagami et al., 2004; Drane´ et al., 2010; Lewis et al.,
2010). H3.X and H3.Y amino acids in this region are identical to H3.3 (Fig. 3.1), leading
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to the hypothesis that these putative novel variants might be incorporated by HIRA and/or
Daxx-ATRX in a replication-independent manner.
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Figure 3.1. Amino acid sequence alignment of human histone H3 variants.
Protein sequences of known human histone variants H3.1, H3.2 and H3.3 are aligned with those of novel histone
variants H3.X and H3.Y. Sequence similarity is encoded by background color: identical aa = dark gray, similar
aa = light gray, different aa = white. Black stars indicate described PTMs on known H3 variants, gray
star indicates H3.3 variant specific PTM. Black bar marks peptide sequence used for generation of αH3.X/Y
antibody.
To shed light on the evolutionary origin of these novel variants, further database searches with
H3.X and H3.Y protein sequences were performed, leading to the identification of highly sim-
ilar genes in the chimpanzee (Pan troglodytes: LOC471464 (H3.X ) and LOC471473 (H3.Y ))
and the macaque (Macaca mulatta: LOC718189 (H3.X ) and LOC718280 (H3.Y )) but not
in any other mammalian genome. Predicted H3.X and H3.Y protein sequences of different
primates are almost identical with only few single amino acid changes (Fig. A.2, Appendix).
The most striking difference is the premature stop codon in the macaque H3.X, resulting in
a truncated protein with the size of H3.Y. Interestingly, following nucleotides would code for
the unique H3.X C-terminus.
H3.X and H3.Y genes are located on different chromosomes in the primates analyzed (Pan
troglodytes: chromosome 5, Macaca mulatta: chromosome 6), but the region containing both
loci is in all cases flanked by the CDH18 and the BASP1 gene. These two genes can also be
found on one chromosome in the mouse and rat genome, however, the distance between them
is much shorter. Together, these data give rise to the hypothesis that H3.X and H3.Y loci
originate from gene duplications in evolutionary younger terms and constitute primate-specific
histone variants. To determine which gene was the origin of this duplication, the phylogenetic
tree for the coding nucleotide sequences of human, chimpanzee and macaque H3.X and H3.Y
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together with a variety of other human histone variants was calculated (Fig. 3.2). Clearly vis-
ible in this analysis, H3.X and H3.Y most likely originate from a gene duplication of one of
the H3.3 genes. However, whether the source was H3.3A or H3.3B cannot be answered with
certainty as depending on the sequence used for generating the tree (including or excluding
3’UTR, coding or non-coding sequences), H3.X and H3.Y appear to be closer to the one or
the other (data not shown). In contrast to the human and chimpanzee sequences, macaque
H3.X and H3.Y sequences are more similar to each other than to the respective gene in other
species, which might be due to the premature stop-codon in the macaque H3.X sequence
(Fig. 3.2 and Fig.A.2, Appendix).
In summary, two novel histone H3 variant genes could be identified, termed H3.X and H3.Y,
which seem to be specific for the primate lineage.
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Figure 3.2. Phylogenetic tree of H3.X and H3.Y from different species.
Comparison of coding nucleotide sequences of H3.X and H3.Y from different primates with other human histone
variants, reveals greater similarity of both variants to H3.3 than to any other variant. Hs=Homo sapiens,
Pt=Pan troglodytes, Mm=Macaca mulatta; numbers indicate bootstrap probabilities.
3.2 EndogenousH3.X andH3.Y expression in human cell lines
and tissues
To asses if H3.X and H3.Y are pseudogenes or indeed novel H3 variants, the first step was
to analyze their mRNA expression levels in different human cell lines by quantitative PCR
(qPCR). One primer pair detecting both variants and one primer pair specifically targeting
the unique 3’ sequence of H3.X was chosen because of the high sequence similarity between
H3.X and H3.Y (Fig. A.1, Appendix). Both variants are transcribed at low levels in the
human osteosarcoma cell line U2OS (Fig. 3.3A). Minimal amounts of H3.Y could be detected
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in HEK293 cells, whereas no expression was observed in HeLa cells. As negative control,
mouse NIH3T3 cells were used, showing no expression of H3.X or H3.Y (Fig. 3.3A). In U2OS
cells, H3.Y is stronger expressed than H3.X but absolute expression levels are still very low,
namely ∼16-fold lower than CENP-A (Fig. 3.3B). These data suggest that H3.X and H3.Y
genes are transcribed in some human cell lines, albeit at low total levels.
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Figure 3.3. H3.X/Y mRNA levels in different cell lines and human tissues.
(A) qPCR analysis of endogenous H3.X/Y levels with cDNA from different human and mouse cell lines shows
expression of H3.Y and to a lesser extent H3.X in U2OS cells. Primer pairs amplifying H3.X and H3.Y
(H3.X+Y, blue) or H3.X alone (purple) were used, levels are depicted relative to HPRT1 and HMBS. Error
bars represent SEM of two independent biological experiments. Mouse NIH3T3 cells were used as negative
control showing no H3.X/Y expression. (B) qPCR comparison of endogenous H3.X/Y and CENP-A levels with
cDNA from U2OS cells, reveals approximately 16-fold higher expression of the latter. Primer pairs amplifying
H3.X and H3.Y (H3.X+Y, blue) or CENP-A (gray) were used, levels are depicted relative to HPRT1 and
HMBS. Error bars represent SEM of two independent biological experiments. (C) cDNA prepared from
commercially available total RNA from different normal and malignant human tissues was analyzed by qPCR
for H3.X/Y expression. Tissues positive for H3.X+Y- and H3.X-expression are marked with a ”+”, numbers
of positive samples are indicated in brackets. Controls generated without reverse transcription were used to
assess amplification threshold.
Encouraged by the finding that H3.X and H3.Y are expressed in U2OS cells, the next step
was to analyze primary cells as part of human tissues by qPCR. The initial idea was to
take malignant tissues as U2OS cells are derived from a moderately differentiated sarcoma
of the tibia. In addition, normal tissues for comparison and samples from different brain
regions as well as testis were chosen because of the primate-specific appearance of H3.X and
H3.Y. H3.X/Y levels were quantified with cDNA, synthesized using commercially available
total RNA from the tissues listed (Fig. 3.3C). Interestingly, low but significant expression of
H3.X/Y mRNA could be detected in some bone, breast, lung and ovary tumors. In RNA
from human brain areas and testis, H3.X/Y expression was observed in all samples except
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for the thalamus. In contrast to all other tissues tested, also H3.X mRNA was present in
these brain and testis samples (Fig. 3.3C). In conclusion, mRNAs of novel primate-specific
H3 variants H3.X and H3.Y are not only present in human cell lines, but are also in primary
cells from different human organs.
3.3 Localization, nucleosome structure and chromatin incorpo-
ration of novel tagged H3 variants
To gain insight into the structural features and in vivo behavior of H3.X and H3.Y proteins,
the coding sequences of H3.X and H3.Y were cloned from human cDNA and HeLa cells,
constitutively expressing these with an N-terminal HA-tag, were established. For compari-
son, HeLa cells, constitutively expressing HA-tagged versions of H3.1, H3.2 and H3.3 (here
referred to as ”known H3 variants”) were used. Confocal imaging of these cells shows solely
nuclear localization of all histone H3 variants (Fig. 3.4A). Detection of HA signals in mitotic
cells, co-localizing with mitotic chromosomes, points towards chromatin incorporation of all
tagged H3 variants analyzed. To further address this point, the same cell lines were used
to prepare metaphase chromosome spreads. Immunofluorescence (IF) microscopic analysis of
αHA and DAPI stained spreads shows stable chromatin association of all tagged H3 variants
and a distinct localization pattern of individual variants (Fig. 3.4B).
Since H3.X and H3.Y seem to behave like the known H3 variants regarding their localization
and chromatin association, we were wondering if the sequence differences between novel and
known H3 variants have any influence on protein structure, finally leading to an altered nu-
cleosome structure and stability. In collaboration with Rainer Merkl from the University of
Regensburg, homology models based on the crystal structure of Xenopus laevis H3.2 (Davey
et al., 2002) have been calculated. Overlays of predicted H3.X and H3.Y structures with
H3.2 crystal structure show no major changes in secondary or tertiary structure elements
(Fig. 3.5A). Interestingly, the extra C-terminus of H3.X is proposed to fold into an additional
α-helix. Exchange of both H3.2 chains in the crystal structure of the nucleosome by H3.X or
H3.Y homology models does not result in any sterical clashes with the other histone chains.
Surprisingly, the additional α-helix of the H3.X protein would fit perfectly in the free space
in the middle of the nucleosome, close to the acidic patch of H2A (Fig. 3.5B).
In order to distinguish, whether tagged H3.X and H3.Y are only associated with chromatin or
constitute stable core nucleosomal components, the protein composition of mononucleosomes
in HeLa cells, expressing HA-tagged H3 variants, was analyzed. Clemens Bo¨nisch, another
PhD student in the Hake group, digested isolated chromatin with micrococcal nuclease to
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Figure 3.4. Sub-cellular localization of HA-tagged histone H3 variants.
(A) HA-tagged histone H3 variants localize exclusively to the nucleus in stably transfected HeLa cells as
determined by confocal imaging of interphase cells (left). In mitotic cells, marked by αH3S10ph staining, HA-
tagged histones are associated with condensed chromatin. Cells were co-stained with TO-PRO3 (DNA, gray,
left), αHA (green, middle left) and αH3S10ph (red, middle right). Overlay is shown on the right (merge). Scale
bar equals 5µm. (B) Metaphase chromosome spreads of stably transfected HeLa cells show that all HA-tagged
histone H3 variants are incorporated into chromatin. Depicted are projections of deconvolved widefield images
of chromosomes co-stained with DAPI (DNA, blue, left) and αHA (green, middle). Overlay is shown on the
right (merge). Blow-ups of single chromosomes, indicated by red arrowheads, are depcited on the right panel.
Scale bar equals 10µm.
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mononucleosomes and immunoprecipitated these using αHA antibody. Silver staining of a
15% SDS-gel with bound proteins showed successful precipitation of all four core histones
(Fig. 3.6A, left). Western blotting of an identical gel, probed with αH3 and αH3.X/Y anti-
bodies, revealed the presence of endogenous known H3 variant proteins in all samples except
for the negative control (Fig. 3.6A, right), suggesting the presence of novel and known vari-
ants in the same nucleosome. 2100 Bioanalyzer analysis of bound DNA gave a single signal,
corresponding in its size to mononucleosomal DNA (∼146 bp), thereby verifying digestion
to mononucleosomes (Fig. 3.6B). Taken together, these data show that HA-H3.X and -H3.Y
constitute core nucleosomal components and are, in contrast to H3.1 and H3.3 (Tagami et al.,
2004), able to form heterotypic nucleosomes with known H3 variants.
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Figure 3.5. In silico homology models of H3.X and H3.Y protein structure.
(A) Overlays of H3.2 crystal structure (blue) with H3.X (purple, left) or H3.Y (cyan, right) in silico homology
models. Predicted tertiary structures of both novel variants are almost identical to H3.2. Extended C-terminal
tail of H3.X is proposed to fold into an additional α-helix (boxed area). (B) Both H3.2 molecules in the crystal
structure of the nucleosome are replaced by H3.X (purple, left) or H3.Y (cyan, right) homology models. The
additional α-helix of the H3.X protein is predicted to fold into the free space in the middle of the nucleosome,
close to the acidic patch of H2A.
Next we wanted to analyze the in vivo stability of nucleosomes containing different H3 vari-
ants. These experiments were performed by our collaboration partner Lothar Schermelleh
from the LMU Munich and his group. Novel and known H3 variants were cloned with an
N-terminal GFP-tag under a constitutively active promoter and transiently transfected into
HeLa Kyoto cells. These cells were chosen because of their slow cell motility. In a small area of
the nucleus, the fluorescence signal was bleached, followed by a measurement of fluorescence
recovery after photobleaching (FRAP) rates. All H3 variants show virtually no recovery of
the fluorescence signal, even after 8 h, arguing for highly stable chromatin components. In
contrast, GFP alone recovers within seconds (Fig. 3.7A,B). Quantification of long-term FRAP
rates (Fig. 3.7B, bottom) indicates some minor differences between H3 variants, however, these
differences are within the dynamic range of the method as illustrated by long-term FRAP
curves including error bars (Fig. 3.7C).
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Figure 3.6. Composition of H3.X and H3.Y containing nucleosomes.
Chromatin of HeLa cells, constitutively expressing HA-tagged H3 variants, was digested to mononucleosomes
and used for IP with αHA antibody coupled to magnetic beads. (A) Precipitated material was separated
with 15% SDS-PAGE. Gels were either silver stained (left) or immunoblotted with subsequent Licor analysis
(right) using αHA (red) and αH3 (green) antibodies. All HA-tagged variants (marked with asterisks) were
part of a nucleosome as successful precipitation and presence of all core histones indicate. H3.X and H3.Y
form heterotypic nucleosomes with other H3 variants, shown by H3 signal in Western blotting (right). (B)
DNA of bound and unbound mononucleosomes was isolated and evaluated using the 2100 Bioanalyzer. Gel
picture shows successful digestion and precipitation of DNA (left). Marker bands are depicted in purple and
green. Size analysis of precipitated DNA verifies digestion to mononucleosomes. Asterisks indicate signal of
bound DNA, numbers indicate DNA size in bp (right).
In conclusion, tagged novel variants localize to the nucleus in interphase and mitotic cells, are
incorporated into chromatin and show very slow exchange mobility kinetics. Their behavior as
well as their proposed tertiary structure is highly similar to the known H3 variants, the major
difference being that HA-H3.X and -H3.Y are also able to form heterotypic nucleosomes.
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Figure 3.7. Exchange mobility behavior of GFP-tagged H3 variants.
HeLa Kyoto cells were transiently transfected with GFP-tagged H3 variants or GFP alone. GFP fluorescence
was bleached in a small area of the nucleus and recovery of fluorescence signal was monitored over 1min or
8 h by spinning disk microscopy. (A) Snapshots of one representative cell per construct at several time points
before and after bleaching are depicted. Short-term FRAP analysis shows recovery of GFP signal within
seconds (top), whereas GFP-tagged H3 variants do not show any recovery of the fluorescence signal over 8 h
(bottom). Bleached area is indicated by a white box. Arrows indicate daughter cells after mitosis. Scale bar
equals 5µm. (B) Quantitatification of recovery rates after photobleaching. Mean curves of 10-20 cells are
shown for short-term FRAP analysis (top). Error bars are omitted for clarity (standard deviation +/- 0.02).
For long-term FRAP series (bottom), mean curves of 13-25 cells are plotted. (C) Depicted are mean curves of
long-term FRAP experiments including error bars which represent the respective standard deviation: GFP-
H3.1 (n=13), GFP-H3.3 (n=15), GFP-H3.X (n=18) and HFP-H3.Y (n=25). All GFP-tagged H3 variants
show almost no recovery, indicating stable chromatin incorporation. Subtle differences are within the dynamic
range of the measurement and not statistically significant.
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3.4 Expression and sub-nuclear localization of endogenous
H3.X/Y proteins
Having analyzed endogenous H3.X and H3.Y mRNA expression and characteristics of tagged
novel H3 proteins, the next step was to examine endogenous H3.X and H3.Y protein expres-
sion. Therefore, we developed an H3.X/Y-specific monoclonal rat antibody together with our
collaborator Elisabeth Kremmer from the Helmholtz-Center in Munich. The antibody is di-
rected against amino acids (aa) 9 - 20 of H3.X and H3.Y (for peptide sequence see black line in
Fig. 3.1). Antibody specificity was tested in various assays using HeLa cells stably expressing
HA-tagged H3 variants. αH3.X/Y recognizes acid extracted HA-H3.X and -H3.Y proteins
but none of the other histone variants in Western blot (Fig. 3.8A), IF microscopy (Fig. 3.8B)
and FACS analysis (data not shown). Epitope-specificity was further determined by peptide
competition experiments. αH3.X/Y antibody was incubated with the original peptide used
for antibody generation or an unrelated H3.3 peptide prior to use for IF staining. αH3.X/Y
specifically interacted with the H3.X/Y peptide, which prevented the binding of tagged H3.X
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Figure 3.8. Evaluation of αH3.X/Y antibody specificity.
(A) Western blot analysis of acid extracted histones of HeLa cells, stably transfected with HA-tagged H3
variants. αH3.X/Y antibody recognizes specifically H3.X and H3.Y but none of the other H3 variants (top).
Numbers indicate independently selected HeLa cell populations. Incubation with αHA antibody reveals pres-
ence and equal loading of all tagged variants (bottom). Note that all variants migrate slower than endogenous
H3 (17 kDa) because of the HA-tag. H3.X migrates even more slowly because of its extra C-terminus. (B)
IF microscopy images of HeLa cells stably transfected with empty vector, HA-H3.X or HA-H3.Y, co-stained
with DAPI (DNA, blue, left) and αH3.X/Y (green, middle), shows nuclear localization of tagged H3.X and
H3.Y protein. Merged pictures are depicted on the right, scale bar equals 5µm. (C) Peptide competition
assay to evaluate epitope-specificity of αH3.X/Y antibody. HeLa HA-H3.X cells were co-stained with DAPI
(DNA, blue, left) and αH3.X/Y (green, middle) pre-incubated with an H3.3 (aa 22 - 41) peptide (top) or
H3.X/Y (aa 9 - 20) peptide (bottom). HA-H3.X signal is lost in a H3.X/Y-sequence specific manner. Overlay
is depicted on the right (merge). Insets show blow-ups of two representative cells. Scale bar equals 50µm.
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in the cell, leading to a loss of fluoresence signal. No binding of αH3.X/Y to the H3.3 peptide
occured, thereby giving a strong signal for HA-H3.X (Fig. 3.8C).
With this highly specific tool, acid extracted histones from several human cell lines were
analyzed for their content of endogenous H3.X/Y protein. Mouse NIH3T3 cells served as
negative and HeLa HA-H3.X cells as positive control. Western blot analysis of these histones
using αH3.X/Y antibody, revealed a faint band at 17 kDa for U2OS histones but not for
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Figure 3.9. Endogenous H3.X/Y expression and sub-nuclear localization.
(A) Western blot analysis of acid extracted histones from different cell lines with αH3.X/Y antibody reveals
a faint band for U2OS cells at 17 kDa but not for any other cell line (top). HeLa HA-H3.X cells were used
as positive, mouse NIH3T3 cells as negative control. Membrane was stained with Ponceau S to check protein
loading (bottom). Dotted lines indicate that intervening lanes have been spliced out. (B) Confocal imaging
of U2OS cells co-stained with αH3.X/Y (green), H3S10ph (mitosis-specific, red) and TO-PRO3 (DNA, gray)
shows a distinct pattern of H3.X/Y staining associated with the nuclear envelope in all inter- and prophase
cells, as well as a general nuclear staining in very few cells (marked by a red arrowhead). Scale bar equals
10µm. (C) Confocal imaging of mouse NIH3T3 and rat neuroblastoma cells co-stained with αH3.X/Y (green),
H3S10ph (red) and TO-PRO3 (DNA, gray), used as negative control, shows no H3.X/Y staining. Scale bar
equals 10µm. (D) Confocal imaging of a mitotic U2OS cell co-stained with TO-PRO3 (DNA, gray, left),
αH3.X/Y (green, middle left) and H3S10ph (red, middle right) shows chromatin association of H3.X/Y signal.
Overlay is shown on the right, scale bar equals 10µm. (E) Chromosome spreads of mitotically arrested
U2OS cells show chromatin incorporation of H3.X/Y signal. Depicted is a projection of deconvolved widefield
images of U2OS metaphase chromosome spreads co-stained with DAPI (DNA, blue, left) and αH3.X/Y (green,
middle). Overlay is shown on the right, inset shows an enlargement of a single chromosome, indicated by a
red arrowhead. Scale bar equals 10µm. (F) Super-resolution 3D-SIM IF analysis of U2OS cells expressing low
(left) or high (right) amounts of H3.X/Y co-stained with DAPI (blue) and αH3.X/Y (green). Scale bar equals
5µm. Enlargements of boxed sections are depicted on the right with scale bar equaling 1µm. H3.X/Y signal
is mostly found outside of DAPI-dense regions. In (B)-(D) and (F) confocal mid-sections are shown.
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histones of any other cell line (Fig. 3.9A). These data are consistent with previous findings,
as the size of this band would be expected for H3.Y and U2OS cells express mostly H3.Y
mRNA (see Fig. 3.3A). Moreover, in confocal images of U2OS cells stained with αH3.X/Y, a
strong nuclear staining, co-localizing with DNA, was detected in some few cells but not in any
other cell line (Fig. 3.9B, arrowhead). However, in all human cells, a dotted H3.X/Y stain-
ing associated with the nuclear envelope was visible (Fig. 3.9B and section 3.8). In contrast,
mouse and rat cells, which were used as negative controls, do not display any H3.X/Y signal
(Fig. 3.9C). In H3.X/Y expressing mitotic U2OS cells as well as in chromosome spreads of mi-
totically arrested H3.X/Y expressing U2OS cells, H3.X/Y signal is associated with condensed
chromosomes, arguing for a stable chromatin incorporation of endogenous H3.X/Y protein
(Fig. 3.9D,E). As seen for HA-tagged novel variants, H3.X/Y staining shows a distinct distri-
bution along chromosome arms (Fig. 3.9E). To shed light on the sub-nuclear localization of
endogenous H3.X/Y protein, our collaborator Lothar Schermelleh performed super-resolution
imaging with 3-dimensional structured illumination microscopy (3D-SIM) analysis (Gustafs-
son et al., 2008; Schermelleh et al., 2008). This method provides the possibility to acquire
images with a resolution below the diffraction limit of conventional optical microscopes and
therefore allows to determine sub-nuclear localization of proteins more accurately (Fig. A.3,
Appendix). In U2OS cells, co-stained with αH3.X/Y and DAPI, this technique finds the
H3.X/Y signal primarily outside of DAPI-dense region, irrespective of H3.X/Y expression
levels (Fig. 3.9F). This finding suggests an association of H3.X/Y with less condensed and
more euchromatic areas.
In summary, these data show that endogenous H3.X and/or H3.Y protein is expressed in
U2OS cells. It localizes to the nucleus, is incorporated into chromatin and seems to be asso-
ciated with more euchromatic areas.
3.5 Induction of endogenous H3.X/Y expression in U2OS cells
3.5.1 Increase in H3.X/Y expressing U2OS cells through nutritional and
proliferative stress
Previous analyses of U2OS cell samples have shown that only less than 0.1% of cells show a
general nuclear H3.X/Y staining in IF microscopy. In addition, this percentage as well as the
amount of H3.X+Y mRNA, determined in qPCR measurements, varies considerably between
biological replicates. Wondering what causes these fluctuations, some kind of stress stimulus
was hypothesized to trigger H3.X/Y expression in U2OS cells. Together with Silke Mildner, a
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diploma student in the Hake group, whom I supervised, I set out to test this hypothesis. The
first set of stress conditions tested were UV irradition, causing DNA damage and at higher
doses apoptosis, and proliferative stress or proliferative stress concomitant with starvation.
UV treatment did not change the number of U2OS cells showing a general nuclear αH3.X/Y
staining (Fig. 3.10) nor did hydroxyurea or etoposide, which induce DNA damage via other
pathways than UV (data not shown). Interestingly, proliferative and nutritional stress to-
gether but not proliferative stress alone led to a 4-fold increase in the number of αH3.X/Y
stained nuclei (Fig. 3.10).
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Figure 3.10. Test of different stress conditions as trigger for H3.X/Y expression in U2OS cells.
U2OS cells were grown under different stress conditions for 8 days (normal, overgrowth or starvation and
overgrowth) or treated with different doses of UV light to induce DNA damage and apoptosis (for details see
section 2.3.1.2). Cells were co-stained with DAPI (DNA) and αH3.X/Y and percentage of cells showing a
general nuclear staining was calculated and plotted (for details see section 2.3.4). Starvation and overgrowth
but not overgrowth alone leads to an increase in the number of H3.X/Y expressing cells, whereas DNA damage
and apoptosis does not show any effect.
Based on these findings, we next examined if starvation alone or only together with high cell
density can lead to an increase in U2OS cells positive for αH3.X/Y staining. We cultivated
U2OS cells for 8 days under different stress conditions (normal, starvation or starvation and
overgrowth), calculated the percentage of cells with general nuclear αH3.X/Y staining from
IF microscopy data, quantified H3.X/Y mRNA levels by qPCR and analyzed H3.X/Y protein
levels by Western blotting using αH3.X/Y. With these experiments we could reproducibly
show that starvation and overgrowth (SO) increases the number of cells with αH3.X/Y-
positive nuclei by approximately 6-fold, whereas starvation (S) alone only leads to a 3-fold
increase (Fig. 3.11A). H3.X+Y mRNA levels are likewise affected (Fig. 3.11B). In Western
blot analysis of acid extracted histones, the 17 kDa band, only faintly visible in the lane with
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histones from normally grown U2OS cells, appears much stronger after both stress treatments
(Fig. 3.11C). Comparison with recombinant H3.X and H3.Y proteins loaded as size markers
and positive controls, suggests that specifically H3.Y rather than H3.X protein levels are
increased. This is in accordance with the mRNA data that show a stronger enrichment of
H3.X+Y than H3.X amplicons, thereby arguing that these stress stimuli act particularly on
H3.Y expression.
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Figure 3.11. Increase of H3.X/Y expressing U2OS cells by nutritional and proliferative stress.
U2OS cells were grown for 8 days under different stress conditions (normal, starvation or starvation and
overgrowth) and subsequently analyzed for number of cells showing a general nuclear H3.X/Y staining, H3.X/Y
mRNA and protein levels. (A) Cells were co-stained with DAPI (DNA) and αH3.X/Y and percentage of cells
showing a general nuclear staining was calculated and plotted (for details see section 2.3.4). Starvation and
overgrowth, and to a lesser extent starvation alone, increases number of cells with general nuclear H3.X/Y
staining. Error bars represent SEM of three independent biological experiments. (B) H3.X/Y mRNA levels
were quantified by qPCR using cDNA. H3.X+Y (blue) and H3.X (purple) levels are shown relative to HPRT1
and HMBS and normalized to normally grown U2OS cells. Nutritional and proliferative stress significantly
increases H3.X+Y, but not H3.X levels. Error bars represent SEM of three independent biological experiments.
(C) Acid extracted histones were analyzed for H3.X/Y protein levels by Western blotting using αH3.X/Y
antibody (top). Recombinant H3.X and H3.Y proteins served as positive, acid extracted histones from HeLa
and mouse NIH3T3 cells as negative controls. Ponceau S staining ensured equal protein loading (bottom).
Starvation with and without overgrowth leads to an increase of a 17 kDa band in U2OS cells. One representative
blot of three independent biological experiments is shown.
To further validate that indeed H3.Y expression is mostly affected by S and SO treatment,
qPCR analysis with cDNA from one biological replicate of the above stress experiments (see
Fig. 3.11) was performed, using several primer pairs targeting H3.X and H3.Y mRNA or
specifically the one or the other. Amplicons were chosen to span the complete coding se-
quence of both variants (Fig. 3.12B). H3.X mRNA levels stay virtually constant upon S and
SO treatment, whereas H3.Y-specific as well as some of the H3.X+Y-specific amplicons show
a strong enrichment (Fig. 3.12A), confirming previous findings. Primer pair H3.X+Y#3 has
previously been identified as the most sensitive of the H3.X+Y primer pairs. For data de-
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Figure 3.12. Evaluation of inducible endogenous H3.X and H3.Y expression.
(A) qPCR analysis of cDNA from U2OS cells grown under different stress conditions using different primer
pairs for H3.X and H3.Y. The result of one of the three biological replicates depicted in Fig. 3.11 is shown.
(B) Amplicons generated by three H3.X+Y-specific (shades of blue), two H3.X-specific (shades of purple) and
two H3.Y-specific (shades of cyan) primer pairs span the complete coding regions (”primer-walk”). For primer
sequences see Table A.1.
picted in Figs. 3.3A and 3.11B, primer pairs H3.X+Y#2 and H3.X#2 have been used.
To assess the question which factor(s) in the growth medium cause the observed effects, cells
were also scored for αH3.X/Y-staining after serum-starvation, amino acid-depletion or growth
under reduced oxygen levels, none of which had a reproducible effect on H3.X/Y expression
(data not shown).
In summary, these data show a direct correlation between αH3.X/Y nuclear staining, H3.X/Y
mRNA and protein levels, all being upregulated by starvation and overgrowth and to a lesser
extent starvation alone. Furthermore, they suggest that particularly H3.Y expression is pos-
itively affected by these treatments.
3.5.2 Increase of endogenous H3.Y protein expression in U2OS cells after
SO treatment
SO treatment increases the number of cells with αH3.X/Y nuclear staining, presumably
caused by enhanced expression of H3.Y. To confirm this assumption, novel histone H3 vari-
ants were purified from U2OS cells and analyzed using mass spectrometry. Total histones
were isolated from normally grown or SO treated U2OS cells and separated using reversed
phase-high performance liquid chromatography (RP-HPLC) (Fig. 3.13A). Histone H3 vari-
ants elute in two peaks: peak I contains H3.2 and H3.3 whereas peak II contains only H3.1
protein (Fig. 3.13B) (Hake et al., 2006). Fractions 1 - 30, corresponding to histone H3 peaks,
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Figure 3.13. Purification and identification of endogenous H3.Y protein.
Acid extracted histones of normally grown and SO treated U2OS as well as HEK293 and mouse NIH3T3 cells
were separated by RP-HPLC and fractions containing H3 variants were analyzed by Western blotting and
mass spectrometry. (A) Typical histone RP-HPLC peak profile. Box indicates fractions used for analysis. (B)
An enlargement of boxed section marked in (A) is shown. (C) Western blots with fractions 1-30 (marked in
(B)) from different cell lines using αH3.X/Y antibody, show a weak band at 17 kDa in normally grown U2OS
cells (A band, ii), which is strongly enhanced after SO treatment (A bands, iii) and not visible in any other
cell line. Region B bands (∼35 kDa) are present in all human but not in mouse cells (ii-iv versus v). Ponceau
S staining of U2OS SO membranes visualizes protein content in individual fractions (i). Dotted lines indicate
that intervening lanes have been spliced out. (D) Fractions containing region B bands and fractions containing
H3.1, H3.2 and H3.3 were treated with different amounts of DTT. Western blotting using αH3.X/Y for region
B band fractions (left) and αH3 for H3 fractions (right) shows dissociation of H3 dimers but no effect on region
B bands. (E) List of H3 and H3.X/Y peptides identified in combined region A fractions of normally grown
and SO treated U2OS cells in LC-MS/MS analyses. Amino acids marked in bold are specific for H3.X and
H3.Y, bold and underlined amino acid is H3.Y-specific. For MS/MS spectra see Fig. A.4.
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were analyzed on Western blots probed with αH3.X/Y. Ponceau staining of membranes with
histones from SO treated U2OS cells, shows amount of canonical H3 present in individual
fractions (Fig. 3.13Ci). Proteins detected by αH3.X/Y elute right before peaks I and II
(Fig. 3.13Cii,iii). As expected, a faint 17 kDa band, indicative of H3.Y, can be observed in
normally grown U2OS cells and is strongly enhanced in SO treated cells (region A bands in
Fig. 3.13Cii and iii). In addition, a 35 kDa protein, showing the same intensity under both
growth conditions, is also detected by αH3.X/Y (region B bands in Fig. 3.13Cii and iii). For
comparison, total histones from human HEK293 and mouse NIH3T3 cells were RP-HPLC-
purified and corresponding fractions analyzed on Western blots. Both cell lines show no
signal for region A bands, however, a strong region B band signal can be observed in HEK293
cells, proposing the corresponding protein to be present in all human but not in mouse cells
(Fig. 3.13Civ,v). The size of the protein causing region B band signals is approximately twice
the size of H3.X and H3.Y, giving rise to the idea that it might constitute a homo- or het-
erodimer of novel H3 variants. To test this hypothesis, region B band fractions and a mixture
of peak I and II fractions were treated with increasing amounts of DTT to reduce disulfide
bonds and thereby separate potential H3 dimers. Peak I and II fractions contain minimal
amounts of H3 dimers, which can be separated using high DTT concentrations (Fig. 3.13D).
No such effect on proteins in region B band fractions can be observed, arguing against a
dimerization of novel H3 variants. Region A, as well as region B band fractions, were sub-
jected to mass spectrometrical analysis using nano-ESI-LC-MS/MS. For proteins present in
region B band fractions only one single peptide corresponding to H3.X/Y (aa 53 - 63) could be
observed among several others, rendering the analysis of these fractions inconclusive. How-
ever, for proteins present in region A band fractions, two H3.X/Y-specific (aa 53 - 63 and
aa 73 - 83), as well as one H3.Y-specific (aa 18 - 28) peptide, could be identified in addition
to common H3 peptides in two biological replicates of SO treated and in normally grown
U2OS cells (Fig. 3.13E and Fig.A.4A-C, Appendix). Interestingly, the H3.Y-specific peptide
was also found to be acetylated on K18, K23 and K27 in some cases in both SO treated and
normally grown U2OS cell samples (Fig. A.4D,E, Appendix). These PTMs are also present
in canonical H3 variants, indicating that H3.Y was likely part of a nucleosome and present in
chromatin fibers.
In summary, these data show that posttranslationally modified H3.Y is expressed in U2OS
cells and that its levels are increased upon SO treatment.
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3.6 Effects of H3.Y on gene expression
Previous experiments have shown that H3.X and H3.Y genes are expressed in vivo and that
at least H3.Y constitutes a novel histone H3 variant. To examine the biological function(s)
of H3.Y expression, RNA expression profiles of cells expressing enhanced or reduced levels of
H3.Y have been generated. For both sets of experiments the hybridization was carried out
by Dietmar Martin and Kerstin Maier of the Gene Center Affymetrix Microarray Platform
(LMU Munich, Cramer Laboratory) and data analysis was performed by our collaborator
Tobias Straub (LMU Munich, Becker Laboratory).
3.6.1 De-regulation of genes mainly implicated in growth control, survival
or differentiation pathways in HeLa HA-H3.Y cells
The number of H3.Y expressing U2OS cells varies considerably between different samples.
Therefore, the initial idea was to use HeLa cells constitutively expressing HA-tagged H3.Y
and compare their RNA expression profile with that of empty vector transfected HeLa cells.
Total RNA was isolated from two independently selected HeLa HA-H3.Y and HeLa empty
vector cell populations, respectively, and hybridized to Affymetrix Human Gene 1.0 ST arrays.
In HeLa HA-H3.Y cells, 119 genes were significantly up- and 73 significantly down-regulated
(local false disvovery rate cutoff 0.2). The most upregulated gene was H3.Y (LOC391769),
thereby verifying the sensitivity and accuracy of the assay. Gene ontology (GO) enrichment
analysis revealed that affected genes are mainly implicated in growth control, survival or
   Odds Exp
GOBPID     Pvalue   Ratio   Count   Count   Size   Term
GO:0007165  0.000  3.171  18  38  2297  signal transduction
GO:0060389  0.000  41.146  0  4  17  pathway-restricted SMAD protein phosphorylation
GO:0007167  0.000  5.086  2  10  288  enzyme linked receptor protein signaling pathway
GO:0050789  0.000  2.405  38  55  4916  regulation of biological process
GO:0008285  0.000  4.982  2  8  230  negative regulation of cell proliferation
GO:0060021  0.001  20.828  0  3  22  palate development
GO:0007179  0.001  8.010  1  5  89  transforming growth factor beta receptor signaling pathway
A
B    Odds Exp
GOBPID     Pvalue   Ratio   Count   Count   Size   Term
GO:0040008  0.000  8.673  1  6  204  regulation of growth
GO:0045661  0.000  87.256  0  2  8  regulation of myoblast differentiation
GO:0008361  0.000  8.898  1  5  162  regulation of cell size
GO:0045987  0.001  74.784  0  2  9  positive regulation of smooth muscle contraction
GO:0048741  0.001  19.122  0  3  45  skeletal muscle fiber development
Figure 3.14. GO enrichment analysis of de-regulated genes in HeLa HA-H3.Y cells.
List of GO terms resulting from an enrichment analysis of significantly up- (A) or down- (B) regulated genes in
HeLa HA-H3.Y relative to HeLa empty vector cells as determined by microarray analysis. Size= total number
of genes analyzed in this node (GO term), ExpCount=number of ”responders” expected (entering the term
by chance), Count=actual number of ”responders” found in the node.
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differentiation pathways (Fig. 3.14). Before analyzing the biological meaning of this result,
several controls have been performed. As the array used is rather new, the first step was
to validate the microarray results for a selection of genes. 9 of the strongest ”responders”
were chosen as well as the 7 most de-regulated genes in the listed GO groups. cDNA was
synthesized from the same RNA used for microarray analysis, expression levels were quan-
tified by qPCR relative to HPRT1 and HMBS and results were normalized to empty vector
transfected HeLa cells. Comparison of microarray and qPCR data for these loci shows a
general correlation of expression data (Fig. 3.15, left). However, depending on the localiza-
tion of the primers and the uniformity of the data determined from individual probesets,
the actual results differ to a certain extent. Another important question is the distinction
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Figure 3.15. Gene expression levels in HeLa cells stably expressing HA-tagged H3 variants.
Comparative qPCR analysis of cDNA from HeLa cells stably expressing HA-tagged H3.1, H3.3 or H3.Y with
primer pairs for two subsets of genes, de-regulated in HeLa HA-H3.Y relative to HeLa empty vector cells. On
the left, microarray data normalized to HeLa empty vector and on the right, qPCR results relative to HPRT1
and HMBS and normalized to HeLa empty vector are plotted. Error bars represent SEM of two independently
selected HeLa cell populations. Subset 1 genes (top) were selected from the strongest ”responders” in microar-
ray analysis of HeLa HA-H3.Y compared to HeLa empty vector cells. Subset 2 genes (bottom) are significantly
de-regulated in HeLa HA-H3.Y cells and part of GO groups listed in Fig. 3.14.
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between H3.Y-specific effects and effects that result from the constitutive expression of any
tagged H3 variant. Therefore, the same loci used for validation of the method, were analyzed
for their expression levels in HeLa HA-H3.1 and -H3.3 cells using qPCR. Some of the genes
strongly de-regulated in HeLa HA-H3.Y cells show almost no change in HeLa HA-H3.1 and
-H3.3 cells (e.g. APLF), arguing for an H3.Y-specific effect, but several other genes, such as
CXCL16 or IGFBP3, are de-regulated similarly in all three cell lines (Fig. 3.15, right). As
these results make it impossible to deduce a general biological meaning from the expression
data in HeLa HA-H3.Y cells without having the corresponding data for HeLa cells expressing
other H3 variants, we decided to compare expression levels of individual de-regulated genes
in HeLa HA-H3.Y with normally grown U2OS HA-H3.Y cells and U2OS and U2OS HA-H3.Y
cells grown under SO conditions for 8 days. With this dataset, cell line dependent and gen-
eral effects of HA-H3.Y can be distinguished from each other. Furthermore, effects of SO
treatment can be compared to those caused by constitutive HA-H3.Y expression. Expression
levels determined by qPCR are shown relative to HPRT1 and HMBS and normalized to U2OS
empty vector cells, normally grown U2OS and U2OS HA-H3.Y cells, respectively. For HeLa
HA-H3.Y, qPCR data shown in Fig. 3.15 (bottom) are depicted (Fig. 3.16). Comparison of
expression levels in HeLa HA-H3.Y and U2OS HA-H3.Y cells, shows huge differences, arguing
for a strong influence of the cellular background on HA-H3.Y function (Fig. 3.16, light brown
vs. light blue bars). Dickkopf 1 (DKK1) for example, shows only mild up-regulation in HeLa
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Figure 3.16. Influences of HA-H3.Y expression and SO treatment on gene expression.
Comparative qPCR analysis of cDNA from HeLa HA-H3.Y, U2OS HA-H3.Y, U2OS SO and U2OS HA-H3.Y SO
cells with primer pairs for subset 2 genes (see Fig. 3.15) shows cell line dependent effects of HA-H3.Y expression
and no consistent synergistic effects of HA-H3.Y expression and SO treatment. Expression levels are calculated
relative to HPRT1 and HMBS and shown as fold enrichment over HeLa empty vector, U2OS empty vector,
normally grown U2OS and normally grown U2OS HA-H3.Y cells, respectively. Error bars represent SEM of
two independently selected HeLa cell populations (HeLa HA-H3.Y) or two biological replicates (U2OS SO).
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HA-H3.Y cells whereas levels are strongly increased in U2OS HA-H3.Y cells. As DKK1 is
implicated in bone formation (Pinzone et al., 2009) and U2OS cells constitute bone derived
cells, this difference is most likely caused by basic differences between HeLa and U2OS cells.
In contrast to these extreme discrepancies, growth arrest specific protein 1 (GAS1) and the
transforming growth factor β (TGFβ) -target sphingosine kinase (SPHK1) (Donati et al.,
2009) show reduced levels in both cell lines, arguing for H3.Y-specific effects. Based on the
finding that H3.Y expression is induced in U2OS cells after SO treatment, we hypothesized
that HA-H3.Y expression and SO treatment have similar effects. However, this is not the
case for any of the genes analyzed (Fig. 3.16, light vs. middle blue bars). The cause for this
discrepancy is presumably that SO treatment affects the expression of many genes other than
H3.Y. Analyzing the data with regard to synergistic effects of HA-H3.Y expression and SO
treatment, the emerging picture is quite complex (Fig. 3.16, middle vs. dark blue bars). For
several genes, such as SMAD6, an inhibitor of the TGFβ-cascade (Moustakas and Heldin,
2009) or insulin-like growth factor binding protein 3 (IGFBP3), which is known to stimulate
TGFβ-signaling via the SMAD-pathway (Fanayan et al., 2000, 2002), SO treatment causes
a reduction of gene expression, which is stronger when in addition HA-H3.Y is expressed,
thereby showing a synergistic effect. For other genes, HA-H3.Y expression seems to do the
contrary by attenuating the effect of SO treatment. Examples are GAS1 and TGFβ receptor
2 (TGFBR2) which activates the TGFβ-cascade (Moustakas and Heldin, 2009).
Taken together, these data show that H3.Y influences gene expression in a cell type specific
manner. Since HeLa cells do not express endogenous H3.Y (see Fig. 3.3A), it is impossible to
deduce the biological role of this novel variant from HeLa HA-H3.Y expression data.
3.6.2 Impairment of cell proliferation in U2OS cells after knockdown of
H3.Y or H3.X+Y
To gain a deeper insight into the biological function(s) of H3.Y, U2OS cells with reduced
endogenous H3.Y mRNA and protein levels after RNA interference (RNAi) -knockdown were
used for global transcriptome analysis, a system closer to the in vivo situation than the con-
stitutive expression of tagged protein. Due to the high sequence similarity of H3.X and H3.Y
(see Fig. A.1, Appendix), only one small interfering RNA (siRNA) specifically targeting H3.X
and one targeting H3.Y could be designed. In addition, one siRNA directed against both
mRNAs (H3.X+Y) was used and control knockdowns were performed using luciferase tar-
geting siRNA, a gene not present in human cells (for siRNA sequences see Table A.3). To
test specificity of siRNAs, HeLa HA-H3.X and -H3.Y cells were transfected with siRNAs and
co-stained with αHA and DAPI 4 days later. IF microscopy analysis shows that luciferase
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control knockdown does not affect HA signals in both cell lines, whereas fluorescence signal
is lost in both cases after transfection with H3.X+Y-siRNA (Fig. 3.17). H3.X-siRNA specif-
ically reduces fluorescence signal in HA-H3.X but not in HA-H3.Y expressing HeLa cells,
H3.Y-siRNA shows reversed specificity.
HeLa HA-H3.X
luciferase
H3.X
H3.Y
H3.X+Y
HeLa HA-H3.YsiRNA
mergeDNA αHA mergeDNA αHA
Figure 3.17. Evaluation of H3.X/Y siRNA specificity.
IF microscopy analysis of HeLa HA-H3.X (left) and -H3.Y (right) cells 4 days after siRNA transfection, shows
specificity of H3.X-, H3.Y- and H3.X+Y-siRNAs. Cells were co-stained with DAPI (DNA, blue, left) and αHA
(green, middle), overlay is shown on the right (merge). Scale bar equals 20µm.
For global transcriptome analysis, two independent double siRNA-knockdowns of H3.Y,
H3.X+Y and luciferase control in SO treated U2OS cells were performed. RNA was isolated
and knockdown efficiency monitored by qPCR analysis (Fig. 3.18A). RNA was hybridized to
Affymetrix Human Gene 1.0 ST arrays and expression levels in H3.Y and H3.X+Y relative
to luciferase knockdown cells were determined. In H3.Y-siRNA knockdown cells, 293 genes
were up- and 974 genes down-regulated, whereas cells treated with H3.X+Y-specific siRNAs
showed 1106 up- and 1249 down-regulated genes (local false discovery rate cutoff 0.2). To
eliminate H3.X-specific and off-target effects, genes de-regulated after both knockdowns were
identified. Numbers of shared up- (73) and down-regulated (229) genes are depicted in Venn
diagrams (Fig. 3.18B). GO enrichment analysis of overlapping genes revealed a long list of
affected GO groups comprising, among others, cell cycle-controlling, chromatin organization,
metabolic and signaling pathways (Fig. A.5, Appendix). To elucidate the connection between
these groups, a simplified GO list was generated, containing major groups affected by the
applied treatment. For shared up-regulated genes no such group could be identified, but
down-regulated genes turned out to be mostly implicated in mitosis and DNA conforma-
tion changes (Fig. 3.18C). Since H3.Y seems to be implicated in mitosis and we previously
noticed a reduction in cell number after H3.Y and H3.X+Y knock-down, U2OS cells were
analyzed for their proliferation capacity after knockdown of H3.Y or H3.X+Y. Treatment
65
3 Results
A
H3.Y-siRNA H3.X+Y-siRNA
1020745 229
1033220 73
H3.Y-siRNA
H3.X+Y-siRNA
B
0
0.5
1.0
1.5
F
ol
d 
en
ric
hm
en
t /
 U
2O
S
 +
 lu
ci
fe
ra
se
-s
iR
N
A
CDC20, NUF2, ASPM, NSL1, KIF11, NCAPD3, NCAPD2, 
CDK2, NUP37, C14orf106, CDC6, CDC27, NDC80, BUB1, 
AURKA, NCAPG, MAD2L1, CCNA2, TTK, PBK
HIST2H2AC, NCAPD3, NCAPD2, MCM6, HIST1H2BK, 
NCAPG, HIST1H2BH, HIST1H2AH, HIST1H2BM, HIST1H2AB, 
HIST1H2BC, HIST1H2AK, MCM4
GO
number
0007067
0071103
Node 
size
250
120
Sample 
match
20
13
Adjusted 
p-value
2.939134e-08
1.292158e-06
Term
Mitosis
DNA 
conformation 
change
Genes
C
U
P
D
O
W
N
H3.Y-
siRNA
H3.X+Y-
siRNA
luciferase-
siRNA
H3.X+Y
H3.X
H3.Y
Figure 3.18. mRNA expression profiling of U2OS cells after H3.Y or H3.X+Y knockdown.
Total RNA of SO treated U2OS cells transfected twice with siRNAs targeting luciferase, H3.Y or H3.X+Y,
was used for global transcriptome analysis 4 days after first transfection. (A) qPCR analysis of H3.X and H3.Y
levels in cDNA, transcribed from the same RNA used for microarray analysis, verifies efficient knockdown of
H3.Y or H3.X+Y. Data is shown relative to HPRT1 and HMBS and normalized to luciferase-siRNA transfected
cells. Error bars represent SEM of two independent biological experiments. (B) Venn diagrams show numbers
of genes significantly up- (top) or down- (bottom) regulated after H3.Y (red) or H3.X+Y (blue) knockdown as
identified by microarray analysis of two independent biological replicates when compared to luciferase control
knockdown. Overlap represents number of genes that are de-regulated after both knockdowns (purple). (C)
Simplified GO list of genes significantly down-regulated after both knockdowns. For a complete list see Fig. A.5.
Node size= total number of genes analyzed in this node (GO term).
with H3.X-siRNA was also included to determine if novel H3 variants in general play a role
in cell cycle control or if this is specific for H3.Y. Cells were transfected twice with siRNAs
targeting luciferase (control), H3.X, H3.Y or H3.X+Y, seeded in E-plates one day after the
second transfection and cell growth was monitored quantitatively over 96 h using a RTCA DP
Analyzer. Growth curves clearly show that knockdown of both novel variants, but not the con-
trol knockdown, affects cell growth, although the influence of H3.Y seems to be stronger than
that of H3.X (Fig. 3.19A, left). qPCR analysis of H3.X/Y levels 4 days after first transfection,
shows knockdown efficiencies (Fig. 3.19A, right). Interestingly, single siRNA-knockdown of
H3.X and H3.Y in HeLa cells, which do not express detectable amounts of H3.X/Y mRNA (see
Fig. 3.3A), shows a similar growth phenotype for H3.Y, but hardly any effect of H3.X-siRNA
knockdown (Fig. 3.19B). Cells were counted every day starting one day prior to transfection.
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Figure 3.19. Influence of H3.X and/or H3.Y knockdown on proliferation capacity.
(A) U2OS cells were transfected twice with siRNAs targeting luciferase (control), H3.X, H3.Y and H3.X+Y and
seeded in E-plates one day after the second transfection (t= 0 h). Cell growth was monitored over 4 days using
the RTCA DP Analyzer. Error bars represent standard deviation of 4 (luciferase, H3.Y) or 2 (H3.X, H3.X+Y)
technical replicates. Arrows indicate changes of growth medium. qPCR analysis of cDNA, synthesized from
RNA extracted 4 days after first transfection, shows knockdown efficiency (right). H3.X/Y levels are depicted
relative to HPRT1 and HMBS and normalized to luciferase control. (B) HeLa cells were transfected once with
siRNAs targeting luciferase (control), H3.X, H3.Y and H3.X+Y. Cells were counted with the CASY Counter
one day prior to transfection (t= 0 h) and for the following 5 days. Error bars represent standard deviation
of 3 wells processed in parallel. In U2OS cells, knockdown of H3.X, H3.Y and H3.X+Y impair cell growth,
whereas in HeLa cells only the knockdowns of H3.Y and H3.X+Y have this effect.
In summary, it could be shown that the depletion of H3.Y in U2OS cells has a strong effect
on cell proliferation which is also reflected in the de-regulation of genes implicated in mitosis.
Depletion of H3.X also has an impact on cell growth in U2OS but not in HeLa cells, whereas
H3.Y-knockdown has a similar phenotype in both cell lines.
3.7 Expression of endogenous H3.X/Y protein in human brain
So far, expression of endogenous H3.Y protein has only been shown for U2OS cells. However,
expression of H3.Y and partially also H3.X mRNA has been detected in different human tis-
sues (see Fig. 3.3C), suggesting that also the corresponding protein(s) might be expressed in
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Figure 3.20. H3.X/Y expression in human brain.
Confocal imaging of commercially available human hippocampus sections, co-stained with αH3.X/Y (red),
αNeuN (neuronal marker, green), αGFAP (astrocyte marker, white) and DAPI (DNA, blue), reveals H3.X/Y
expression in a sub-population of neurons outside the dentate gyrus. (A) Overview picture of human hip-
pocampus stained with DAPI (DNA). Individual 5x-pictures were merged using the photomerge function of
Adobe Photoshop to create this view. The characteristic band of neurons (dentate gyrus=DG) is indicated
with an arrow. (B) Area above DG with several H3.X/Y positive cells. Note that H3.X/Y overlaps with NeuN
but not GFAP signal. Scale bar equals 20µm. One representative staining out of three is shown. (C) Enlarge-
ment of boxed area indicated in (A). DG is visible at the bottom, arrowheads mark H3.X/Y positive neuronal
cells. Scale bar equals 200µm. One representative staining out of three is shown. (D) Higher resolution image
of H3.X/Y positive cell, marked with an asterisk in (C), shows distinct sub-nuclear localization of H3.X/Y
signal (top). Scale bar equals 2µm. Enlargement of boxed section in (C) shows neurons in the DG without
H3.X/Y staining (bottom). Scale bar equals 10µm.
these tissues. Taking into account that many primate-specific genes are expressed in brain
and reproductive organs (Tay et al., 2009) we chose to analyze commercially available sec-
tions of human hippocampus in IF to address the question of endogenous H3.X/Y protein
expression in human tissues.
Sections were co-stained with αH3.X/Y, DAPI and in addition with αNeuN, marking neurons
and αGFAP, staining astrocytes. Merged confocal images of DAPI-stained tissue with 5x-
magnification shows organization of this brain area with the band of neuron nuclei indicating
the dentate gyrus (DG) (Fig. 3.20A). Several nuclei stain positive with αH3.X/Y, all of them
also showing a NeuN- but no GFAP-signal, identifying them as neurons (Fig. 3.20B). Higher
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resolution images of boxed section marked in Fig. 3.20A finds some few αH3.X/Y stained cells,
all localizing outside the DG (Fig. 3.20C, arrowheads). This finding is in accordance with our
observation that only few U2OS cells show a general nuclear αH3.X/Y staining. Surprisingly,
a close-up view of the H3.X/Y expressing cell indicated with an asterisk in Fig. 3.20C, shows a
distinct sub-nuclear localization pattern of H3.X/Y protein, which is different to the staining
in U2OS cells (Fig. 3.20D, top row). Neurons in the DG (boxed area in Fig. 3.20C) do not
stain positive with αH3.X/Y (Fig. 3.20D, bottom row).
Concluding, H3.X and/or H3.Y protein is expressed in a subpopulation of neurons in the
human hippocampus, highlighting the possibility that novel histone H3 variants might have
cell-type specific functions. H3.X/Y protein(s) localizes solely to the nucleus and shows a
distinct sub-nuclear localization pattern.
3.8 Epression of endogenous H3.X/Y protein in different pri-
mate species
H3.X and H3.Y constitute primate-specific genes. For humans, it could be shown that they
encode for novel histone H3 variants and have an impact on the regulation of many genes
implicated in cell cycle progression, but nothing is known about their expression and function
in other primates. To address this question, primary fibroblasts from several primate species,
each of them representing another branch of the phylogenetic tree of the primate lineage,
were stained with αH3.X/Y and analyzed using confocal microscopy. Although none of the
cells shows a general nuclear staining, as observed for some few cells in U2OS samples (see
Fig. 3.9B), most of them do show the dotted H3.X/Y staining associated with the nuclear
envelope (Fig. 3.21). Interestingly, the only cells that do not show this pattern, are derived
from Eulemur fulvus, which is the most distantly related species to humans in this set, sug-
gesting that H3.X and H3.Y have either evolved after the separation of the primate lineage in
Haplorrhini and Strepsirrhini or the antibody binding site has been destroyed by mutations
in this species. Since mouse and rat cells do not show this dotted αH3.X/Y staining (see
Fig. 3.9C) and the αH3.X/Y antibody has been shown to be highly specific (see Fig. 3.8), it
appears reasonable to think that this signal originates from some kind of H3.X/Y protein.
Fueling this idea is the fact that the annotation of the H3.X locus has changed several times
over the last years, predicting different splice forms (Fig. A.6, Appendix). However, multiple
attempts to clone these alternative H3.X transcripts from human cDNA or quantify them in
qPCR analysis have failed, making the expression of particularly these splice forms unlikely
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Figure 3.21. H3.X/Y expression in primates.
Confocal IF analysis of primary fibroblasts from different primates shows αH3.X/Y staining in all species
analyzed, except for lemurs. The phylogenetic tree of the primate lineage illustrates evolutionary relationships.
Cells were co-stained with TO-PRO3 (DNA, gray, left) and αH3.X/Y (green, middle). Overlay is shown on
the right(merge). HeLa cells serve as positive control. Scale bar equals 10µm.
(data not shown). Furthermore, also purification and subsequent mass spectrometrical iden-
tification of the protein causing this dotted staining has so far not been successful (data not
shown).
In summary, αH3.X/Y antibody detects a protein associated with the nuclear envelope in
several primate species. All attempts to confirm that this protein originates from the H3.X
or H3.Y locus have failed so far. Future studies will have to reveal whether this staining is
caused by another H3.X/Y protein species or is simply caused by a cross-reactivity of the
antibody.
Taken together, it could be shown that H3.Y constitutes a novel histone H3 variant. H3.Y is
expressed in human cells and specialized tissues, incorporated into chromatin, posttranslation-
ally modified, and impacts the regulation of many genes implicated in cell cycle progression.
The role of H3.X remains elusive and will have to be addressed in future experiments.
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4.1 H3.X and H3.Y are novel primate-specific histone genes
Searching the public database with the coding sequence of human histone H3.1, two novel
histone H3 variant genes on human chromosome 5 have been identified, now termed H3.X and
H3.Y. Consecutive database searches found H3.X and H3.Y genes also in the chimpanzee
and the macaque genome but not in any other species. Although sequence data for other
primates are not available yet, the absence of these genes in other mammals or even lower
eukaryotes, suggests that they are primate-specific. Both genes are presumably dublications
of one ancestral gene, as their sequences are highly similar (even in their 5’ and 3’ UTRs),
with some differences in their putative promoter regions. Phylogenetic analysis of coding and
3’ genomic sequences have revealed that H3.X and H3.Y are closer related to H3.3 than to
other H3 variant genes, proposing H3.3 as the origin of H3.X and H3.Y, despite their lack
of introns. The only primate-specific histone variant identified so far is H2BFWT, a protein
only found in testis (Churikov et al., 2004). Interestingly, as observed for the H2BFWT locus,
the genomic region syntenic to H3.X and H3.Y is much shorter in mouse and rat genomes,
suggesting a common mechanism in the evolution of these variant genes.
4.2 Structure and behavior of H3.X and H3.Y proteins is
similar to other H3 variants
Homology models of H3.X and H3.Y predict highly similar protein structures for novel and
known H3. In the H3.X model, the extra C-terminus folds into an additional α-helix (Fig. 3.5)
that is proposed to be in close proximity to one part of the H2A acidic patch (D90, E91, E92).
H2A exposes a stretch of acidic amino acids on the surface of the nucleosome. This negatively
charged patch is bound by the positively charged H4 tail of an adjacent nucleosome (Luger
et al., 1997), thereby promoting folding into higher-order structures (Caterino and Hayes,
2007). Interaction of the H3.X C-terminus with H2A at these sites could stabilize the nucleo-
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some and promote a more open chromatin structure by preventing the H4 tails of neighboring
nucleosomes from binding. Future studies, using in vitro reconstituted chromatin, will ad-
dress this question.
Despite the exchange of several functionally important residues, tagged H3.X and H3.Y be-
have almost identical to H3.1, H3.2 and H3.3. Matching their high structural similarity,
all variants are stably incorporated into chromatin and show a solely nuclear localization
(Figs. 3.4, 3.6 and 3.7). The only difference that has been observed in mononucleosome IPs
was that H3.X and H3.Y primarily form heterotypic nucleosomes in vivo (Fig. 3.6), whereas
H3.1 and H3.3 are only found in homotypic nucleosomes (Tagami et al., 2004). A similar
behavior has been described for H2A variants H2A.Z (Viens et al., 2006) and macroH2A
(Chakravarthy and Luger, 2006) which both assemble preferentially together with canonical
H2A in nucleosomes.
4.3 H3.X and H3.Y mRNA, but only H3.Y protein is expressed
in human cells
H3.X and H3.Y mRNA are both transcribed in the human osteosarcoma cell line U2OS
(Fig. 3.3A). Some few U2OS cells (<0.1%) show a general nuclear αH3.X/Y staining. This
staining has been shown to be caused by H3.Y, thereby identifying H3.Y as novel primate-
specific H3 variant. So far, it has been impossible to verify the presence of endogenous H3.X
protein, neither for the currently nor for previously annotated transcripts. The expression
of H3.X mRNA, but not H3.X protein in U2OS cells could mean that H3.X is a pseudo-
gene without any function. Alternatively, H3.X could also be a regulatory ncRNA, maybe
even regulating H3.Y expression (for details see section 4.6). In addition to these transformed
cells, expression of H3.Y mRNA at low but significant levels has been detected in some human
bone, breast, lung and ovary tumor tissues, as well as in testis and certain areas of the brain.
Interestingly, H3.X mRNA could also be observed, albeit only in testis and brain (Fig. 3.3C).
Consistent with these findings, H3.X/Y protein has been shown to be expressed in a sub-
population of neurons in the human hippocampus (Fig. 3.20), a brain region which mainly
functions in the formation of long-term memories and the process of learning (Lagali et al.,
2010). Many primate-specific genes are expressed in the brain, but they are not particularly
enriched in this organ relative to all transcripts. In contrast, they are preferentially expressed
in the reproductive system, where they may contribute to speciation (Tay et al., 2009). Taken
together, H3.Y, and maybe H3.X, constitute the first primate-specific histone variants that
are also expressed outside testis, likely confering specialized chromatin functions unique to
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these higher vertebrates. Taking their tissue-specific expression patterns into account, it is
tempting to speculate that H3.X and H3.Y might be involved in the process of speciation
and, even more interestingly, in shaping higher brain functions.
4.4 A putative H3.X/Y protein is associated with nuclear pores
In all human cells and in cells of several closely related primate species, H3.X/Y protein
staining can be observed at the nuclear envelope (Figs. 3.9B,F and 3.21). This staining co-
localizes with nuclear pores as revealed by super-resolution IF analysis (Lothar Schermelleh,
personal communication). Although it has so far not been possible to purify and analyze this
H3.X/Y fraction in closer detail, the occurance of this staining in primates but not in rodents
(Fig. 3.9B vs. C), together with the presence of an additional αH3.X/Y band in purified hi-
stones of human but not mouse cells (B bands in Fig. 3.13C i-iv vs. v), strongly argues for
another H3.X/Y protein in primates. This protein has presumably a size of ∼35 kDa and
associates with nuclear pores. It is most likely not a dimer of H3.X and/or H3.Y (Fig. 3.13D)
or one of the previously annotated H3.X transcripts. Regarding the function of this unusu-
ally localized H3.X/Y fraction, one tantalizing hypothesis is that it tethers certain chromatin
areas to nuclear pores. In yeast, it is well established that nuclear pores are implicated in the
activation of associated genes. Moreover, nuclear pores also act as boundaries that prevent
spreading of active or repressive chromatin marks. Several studies and the high level of con-
servation of some of the involved proteins suggest a similar situation in human cells (Ko¨hler
and Hurt, 2010). Taken together, this could mean that H3.X/Y proteins at the nuclear pore
function as ”insulator histones” that prevent spreading of PTMs, such as the methylation of
H3K79, through the absence of the respective modifiable amino acid.
4.5 The number of H3.Y-expressing U2OS cells is increased by
specific stress stimuli
H3.Y mRNA and protein is expressed in some few U2OS cells under normal growth condi-
tions, but the number of cells expressing this novel H3 variant can be increased by nutritional
starvation in combination with high cell density. Testing whether SO treatment can induce
H3.Y expression also in other cell lines, it turned out that the ability to grow to such high cell
densities is special for U2OS cells. A hint towards the cause for this resistance came from mi-
croarray analyses of HeLa HA-H3.Y cells, where GAS1 was among the down-regulated genes
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(Fig. 3.15). GAS1 blocks cell cycle progression in various cells (Sal et al., 1992, 1994) and is
highly expressed under growth arrest conditions (Schneider et al., 1988). Its downregulation
leads to a loss of contact inhibition and allows higher cell density (Evdokiou and Cowled,
1998). Surprisingly, normally grown U2OS cells have approximately 4-fold lower endogenous
GAS1 mRNA levels than empty vector transfected HeLa cells, giving a possible explanation
for the growth behavior of this cell line.
Although the number of cells expressing endogenous H3.Y is low, the individual cell expresses
high levels (Fig. 3.9B). Compared to HeLa HA-H3.Y cells, the amount of endogenous H3.X+Y
mRNA in these U2OS cells is more than 40-fold higher. This suggests that the induction of
endogenous H3.Y expression is an all or nothing reaction, meaning that when the cell receives
a certain signal or the threshold of an unknown factor is reached, H3.Y is expressed in massive
amounts. The discrepancy in expression levels also explains the shortcoming of HeLa HA-
H3.Y cells as a model system for H3.Y function, underlining the importance of identifying
the main physiological trigger of H3.Y expression for future functional studies.
4.6 H3.Y influences gene expression and cell growth
To address the question of H3.Y’s function, global transcriptome analyses have been per-
formed, using U2OS cells depleted of H3.Y alone or in combination with H3.X. Some hundred
genes were de-regulated after both RNAi knockdowns, implying an influence of H3.Y on gene
expression. Whether this influence is direct or indirect will have to be investigated in future
studies, generating binding profiles of H3.Y using ChIP-chip or ChIP-seq. Interestingly, more
genes were down- rather than up-regulated, arguing for a role of H3.Y in the transcriptional
activation of a subset of genes. In agreement with these results, H3.Y is primarily found in eu-
chromatic regions (Fig. 3.9F). Most of the down-regulated genes are implicated in regulating
the cell cycle and the structure of chromatin, matching the reported growth defect in U2OS
cells with reduced levels of H3.Y (Fig. 3.19A). Surprisingly, although only less than 0.1% of
U2OS cells express H3.Y under normal growth conditions (Figs. 3.9B and 3.10), a strong
and general growth defect is observed after H3.Y knockdown in these cells. It is therefore
possible that all U2OS cells express H3.Y at a basal level (below the detection limit of our
tools) that is crucial for the progression through the cell cycle. In line with this hypothesis,
knockdown of H3.Y in HeLa cells, where no H3.Y mRNA has been detected (Fig. 3.3A), also
strongly impairs cell growth (Fig. 3.19B). Recently, a similar phenotype has been reported
for the linker histone variant H1.2. RNAi depletion of this variant leads to a de-regulation
of ∼2% of genes genome-wide, with most of them being down-regulated. Furthermore, the
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lack of H1.2 causes a G1 arrest and expression changes in cell cycle-related genes (Sancho
et al., 2008). This supports the idea of histone variants as important regulators of cell cycle
progression and suggests that the stress-related appearance of H3.Y expressing U2OS cells
might be caused by continued cell proliferation or the prevention of cell death.
Unlike the strong and cell line independent effect of H3.Y depletion on cell proliferation, the
phenotypes of H3.X knockdown, alone or together with H3.Y, seem to depend on cellular
background (Fig. 3.19). In U2OS cells, combined knockdown of H3.X and H3.Y has a milder
effect on cell growth than H3.Y knockdown alone, whereas in HeLa cells the growth defect ist
almost identical in both cases. Moreover, knockdown of H3.X has hardly any effect on HeLa
cells, but U2OS cells are affected even more than after H3.X+Y depletion. Speculating, this
could mean that H3.X and H3.Y are connected by some sort of regulatory feedback mech-
anism, which would also explain why H3.Y mRNA levels are reproducibly increased after
knockdown of H3.X (Fig. 3.19A, right). HeLa cells might lack this regulation due to a lack of
H3.X.
It will be interesting to see what future studies, investigating the regulatory network of H3.X
and H3.Y, their role in cell proliferation, and in a subpopulation of neurons in the human
hippocampus, will reveal about the endogenous function(s) of these novel H3 variants.
4.7 Outlook
4.7.1 Expression of endogenous H3.X and H3.Y
4.7.1.1 Trigger of H3.X and H3.Y expression in U2OS cells
In this work it could be shown that the number of U2OS cells expressing endogenous H3.Y
(and H3.X) can be increased by nutritional and proliferative stress. However, all attempts to
identify the actual component causing this effect under the described conditions, have failed
so far. To get a better starting material for functional assays and to learn more about the
expression of H3.X and H3.Y, potential candidates, such as signaling molecules or reactive
oxygen species, will be tested for their ability to trigger H3.Y (and H3.X) expression.
4.7.1.2 H3.X and H3.Y promoter activity and regulation
A second approach to learn more about the endogenous expression of H3.X and H3.Y, possibly
giving some indications about the nature of the factor triggering expression, is the analysis of
the respective promoter sequences. Bioinformatic analysis of 1000 bp upstream of the ATG
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using MatInspector (Genomatix Software GmbH) revealed a multitude of potential transcrip-
tion factor binding sites, many of them also implicated in different types of cellular stress.
To shed light on the regulation of endogenous H3.X and H3.Y expression, activity of these
promoters and truncated versions of them will be assessed using a GFP-reporter system on
an episomal vector. Promoter regions of interest will substitute the SV40 promoter of EBO-
Sfi EGFP (SVG) thereby driving GFP expression when the promoter is active (Hake et al.,
2003). To control for the presence of the promoter in the cell, an additional DsRed2 gene
(Clontech) with a separate promoter will be cloned into the vector. SVG will serve as positive
and SVG without any promoter as negative control.
4.7.1.3 H3.X and H3.Y expression in human tissues
Given that H3.X and H3.Y genes are only present in primates, H3.X/Y proteins are expressed
in a sub-population of neurons in the human hippocampus and the major function of this
brain region is the formation of long-term memories and the process of learning (Lagali et al.,
2010), it is tempting to speculate that these novel variants play an important role in the pri-
mate brain. In order to learn more about this interesting possibility, H3.X and H3.Y mRNA
and protein expression will be analyzed by in situ hybridization and immunohistochemistry
in samples of different human brain areas. Since our group is lacking the expertise to identify
structures and cell types specific for certain brain regions and we also do not have access to
human brain samples, a collaboration with a neurobiology group will have to be established
for this part of the project. In addition to different brain regions, H3.X and H3.Y mRNA has
also been detected in several normal and especially malignant human tissues. Therefore, their
expression in human tumors and corresponding normal tissues will be investigated. It will be
interesting to see, whether H3.X and/or H3.Y expression plays a role in the development of
cancer in certain human organs.
4.7.1.4 H3.X and H3.Y expression during cell differentiation
Since novel histone variants show an effect on proliferation, it seems reasonable to think that
they might also play a role in differentiation. However, because of their primate-specific
appearance, it is not possible to use mouse embryonic stem (ES) cells for these assays and
human ES cells are difficult to work with in Germany due to legal restrictions. An elegant way
to circumvent these problems is the expression of Oct3/4, Sox2, c-Myc, and Klf4 in somatic
cells, generating so-called induced pluripotent stem (iPS) cells. These cells behave like ES
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cells, show all the specific features of ES cells and can differentiate into different lineages.
First established for mouse embryonic or adult fibroblasts (Takahashi and Yamanaka, 2006;
Wernig et al., 2007), this approach also works with human somatic cells (Takahashi et al.,
2007; Yu et al., 2007). Using this fascinating tool, it will be possible to follow H3.X and H3.Y
expression during differentiation of human cells.
4.7.2 In vivo function(s) of H3.X and H3.Y
4.7.2.1 Determination of H3.X/Y protein localization
A first step towards a deeper understanding of H3.X and H3.Y function is the high-resolution
mapping of their localization on chromatin. To this end, DNA, isolated from bound material
after αHA-IP of mononucleosomes from HeLa HA-H3.X and -H3.Y cells (see Fig. 3.6), will be
subjected to high throughput sequencing, giving an initial idea about the genetic elements,
H3.X/Y proteins are associated with. After having established a ChIP protocol working with
αH3.X/Y antibody, the localization of endogenous H3.X/Y proteins in U2OS cells will be
mapped using ChIP-chip.
4.7.2.2 Identification of H3.X and H3.Y chaperone(s)
Knowing where H3.X/Y proteins are localized leads to the question of how they are deposited.
Judging from the sequence and what is known about mammalian H3 variant deposition, H3.X
and H3.Y could be incorporated into chromatin by HIRA and/or Daxx (Tagami et al., 2004;
Lewis et al., 2010). However, as this is pure speculation, it will be interesting to identify the
chaperone(s) specific for H3.X and H3.Y protein. Following the procedure successfully used
for identification of the H3.1- and H3.3-specific chaperones CAF-1 and HIRA, respectively
(Tagami et al., 2004), both novel variants will be expressed with C-terminal FLAG- and HA-
or GFP-tags in HeLa cells, tagged proteins will be pulled down from cytoplasmic and nuclear
extracts together with associated (chaperone) complexes, which can subsequently be identi-
fied using mass spectrometry.
4.7.2.3 Replacement of S. cerevisiae H3 with H3.X and H3.Y
S. cerevisiae has two loci encoding for H3 and H4, each containing one H3 (HHT ) and one H4
(HHF ) gene. The genes at each locus are divergently transcribed and give rise to identical
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proteins (Smith and Andre´sson, 1983). We have access to strain WZY42, which has both en-
dogenous loci disrupted and only one functional copy of the endogenous HHT2-HHF2 locus
on a plasmid also encoding the URA3 marker gene (Weber et al., 2004). This strain allows
the exchange of the S. cerevisiae H3 with different human H3 variants, to study their intrin-
sic properties. On plasmid pNOY439 (Keener et al., 1997), which carries the HHT2-HHF2
locus with an N-terminal Myc-tag upstream of the H3 gene and a TRP marker gene, the
yeast H3 gene has been replaced by human H3.1, H3.3, H3.X and H3.Y coding sequences,
respectively. WZY42 will now be transformed with human H3 encoding plasmids and the
plasmid encoding yeast H3 will be removed by selection on 5-fluorouracil (FOA) containing
plates. A first attempt to generate these strains has failed, suggesting that yeast cells are
severely affected by the exchange of endogenous H3 with human variants. This is particularly
interesting as point mutations of most residues, even conserved and modifiable amino acids,
do not impair viability (Nakanishi et al., 2008). It will also be interesting to see, if cells can
cope better with human H3.3 than with the other variants, which would be expected as the
yeast H3 constitutes an H3.3-like protein.
4.7.2.4 Effects of H3.X and H3.Y on cell cycle progression
Microarray analyses and growth curves of U2OS cells with reduced levels of H3.X, H3.Y or
H3.X+Y point towards a role of H3.X and H3.Y in cell cycle progression. To determine where
in this process novel H3 variants function, repeated and careful FACS analysis of the cell cycle
profile in H3.X/Y knockdown cells will be necessary. As effects on the cell cycle profile are
usually quite small and biological fluctuations rather pronounced, a well-founded statistical
analysis will have to be deployed to make a statement about this issue. In addition, cell lines,
expressing HA-H3.Y resistent to H3.Y- or H3.Y+Y-siRNAs, could be established to verify
specificity of observed effects in rescue experiments.
4.7.3 In vitro characterization of H3.X and H3.Y
In parallel to the described experiments aiming to elucidate the function of H3.X and H3.Y
in vivo, additional information can be acquired by characterizing the biochemical properties
of these proteins. For this approach, both proteins have been cloned in vector pET21a(+)
(Novagen) for recombinant expression in BL21-CodonPlus (DE3)-RIL (Stratagene) bacteria.
Proteins will be expressed, purified and octamers of H3.X or H3.Y together with canonical
H2A, H2B and H4 will be assembled. With these octamers, chromatin will be reconstituted
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using a 25- or 12-mer of the 601 nucleosome positioning sequence (Lowary and Widom, 1998).
This highly ”variant pure” substrate can subsequently be used for various assays to determine
the intrinsic stability, accessibility and behavior of H3.X- and H3.Y-containing chromatin
fibers.
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α Anti
aa Amino acid
AOTF Acousto Optic Tunable Filter
Bbd Barr-body deficient
BMP4 Bone morphogenetic protein 4
BSA Bovine serum albumin
CATD Centromere targeting domain of CENP-A
CenH3 Centromere-specific histone H3
ChIP Chromatin immunoprecipitation
DAPI 4’,6-diamidino-2-phenylindole
DG Dentate gyrus
DKK1 Dickkopf 1
DMEM Dulbecco’s Modified Eagle Medium
DMSO Dimethylsulfoxide
Dnmt DNA methyltransferase
3D-SIM 3-dimensional structured illumination microscopy
DSB Double strand break
ELISA Enzyme-linked immunosorbent assay
ES Embryonic stem
FACS Fluorescence-activated cell sorting
FCS Fetal calf serum
FOA 5-fluorouracil
4HB Four helix bundle
FRAP Fluorescence recovery after photobleaching
GAS1 Growth arrest specific protein 1
GFAP Glial fibrillary acidic protein
GO Gene ontology
HEPES 2-(4-(2-Hydroxyethyl)- 1-piperazinyl)-ethansulfonsa¨ure
HFD Histone-fold domain
HIRIP3 HIRA interacting protein 3
HJURP Holliday junction-recognizing protein
HRP Horseradish peroxidase
IF Immunofluorescence
IGFBP3 Insulin-like growth factor binding protein 1
IH Immunohistochemistry
IP Immunoprecipitation
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iPS Induced pluripotent stem
IPTG Isopropyl β-D-1-Thiogalactopyranoside
lfdr Local false discovery rate
MNase Micrococcal nuclease
MS Mass spectrometry
ND Not determined
NeuN Neuronal nuclei
ncRNAs non-coding RNAs
no RevT cDNA samples without reverse transcriptase
ON Overnight
OVA Ovalbumin
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate buffered saline
P/S Penicillin/Streptomycin
PTM Posttranslational modification
qPCR Quantitative PCR
RD Replication dependent
RI Replication independent
RITS RNA-induced initiation of transcriptional gene silencing
RP-HPLC Reversed phase-high performance liquid chromatography
RNAi RNA interference
RT Room temperature
S Starvation
SDS Sodium dodecyl sulfate
SEM Standard error of the mean
siRNA Short interfering RNA
SLBP Stem loop binding protein
SO Starvation and overgrowth
SPHK1 Sphingosine kinase 1
TBS Tris buffered saline
TFA Trifluoroacetic acid
TFBS Transcription factor binding sites
TG Throughout genome
TGFβ Transforming growth factor β
TGFBR TGFβ receptor
UTR Untranslated region
WB Western blot
Xi Inactive X chromosome
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Appendix
Table A.1. Oligonucleotides for qPCR
Name Sequence Description
GAPDH FWD 5’ CTGCACCACCAACTGCTTAG monitoring cDNA
synthesisGAPDH REV 5’ CTTCACCACCTTCTTGATGTC
HPRT1 FWD 5’ AAGGGTGTTTATTCCTCATGGA directed against
reference genes with
stable expression
levels
HPRT1 REV 5’ AATCCAGCAGGTCAGCAAAG
HMBS FWD 5’ AGTGTGGTGGCAACATTGAA
HMBS REV 5’ GCATGTTCAAGCTCCTTGGT
CENP-A FWD 5’ TCACTCGTGGTGTGGACTTC anneal to histone H3
variant CENP-ACENP-A REV 5’ GCACATCCTTTGGGAAGAGA
H3.X+Y #1 FWD 5’ GGACCTGCGCTTCCAGAG
hybridize with H3.X
and H3.Y mRNA
H3.X+Y #1 REV 5’ CATGTCTCGGGGCATAATTG
H3.X+Y #2 FWD 5’ GTCCACGCAGCTGCTCCT
H3.X+Y #2 REV 5’ GGCACACAGGTTGGTGTCTT
H3.X+Y #3 FWD 5’ AAGCAGACCGCCCGCAAAG
H3.X+Y #3 REV 5’ TTCTGATTTCCCGCAGCGCC
H3.X #1 FWD 5’ ACCAAAGCCGCCAGAAAA
hybridize specifically
with H3.X mRNA
H3.X #1 REV 5’ GAGCAGCTGCGTGGACTT
H3.X #2 FWD 5’ GAAGACACCAACCTGTGTGC
H3.X #2 REV 5’ AGTGCAAGGTTTCCCAGGAG
H3.Y #1 FWD 5’ CCACCAAAGCAGCCGGAAA
hybridize specifically
with H3.Y mRNA
H3.Y #1 REV 5’ GCTGCGTGGACTTCTGGTACT
H3.Y #2 FWD 5’ GCCTACCTGGTGCAGCTCTT
H3.Y #2 REV 5’ TTAAGGACCCTCTCTGCGGAGG
H3.X-1 + H3.X-2 FWD 5’ GCCATGGCTGGAATGACC
target different
hypothetical
H3.X-transcripts
H3.X-1 + H3.X-2 REV 5’ GGCCTTGTGCTCTCTCCTCT
H3.X-2 FWD 5’ GAGTCAGAGGCACCCATTG
H3.X-2 REV 5’ CACATGTCCAGAGCCTCTTCT
H3.X long #1 FWD 5’ GCAGGGCTTTACTGAGACCA
H3.X long #1 REV 5’ CAACCCAACCCCACACTTAC
H3.X long #2 FWD 5’ AGCTGGTAAGTGTGGGGTTG
H3.X long #2 REV 5’ CGTCAGAAAACAAGGGCAGT
TMEM177 FWD 5’ CGTGGTCCAATGGCTCTAC
target genes which
show a significant
change in expression
levels after stable
expression of
HA-H3.Y
TMEM177 REV 5’ GAAGGTGAAGGTGGTGAAGG
DCN FWD 5’ GGACCGTTTCAACAGAGAGG
DCN REV 5’ GACCACTCGAAGATGGCATT
IQGAP2 FWD 5’ CAAGATGGTCGTCAGCTTCA
IQGAP2 REV 5’ CACCCAAGCCTTGTACACCT
PKIA FWD 5’ GGGAGAAGCAGCAAAATCTG
PKIA REV 5’ GCAGCACAGCCATTTTCTTT
CYFIP2 FWD 5’ CATCGGCTGCTCTGTAAGC
CYFIP2 REV 5’ TTCAGTTCCCAGAAGACATGC
CGA FWD 5’ CAGAATGCACGCTACAGGAA
CGA REV 5’ AGCAAGTGGACTCTGAGGTGA
CXCL16 FWD 5’ ATGCTTACTCGGGGATTGTG
CXCL16 REV 5’ CAAGGTGGACAGGAGCATCT
APLF FWD 5’ GGGCGACTCACTTCAGGAT
APLF REV 5’ CATGCAGGATGTCCTCTTGA
I
Appendix
Oligonucleotides for qPCR (continued)
Name Sequence Description
NR2F1 FWD 5’ TACGTGAGGAGCCAGTACCC
target genes which
show a significant
change in expression
levels after stable
expression of
HA-H3.Y
NR2F1 REV 5’ CCTACCAAACGGACGAAGAA
BMP4 FWD 5’ GACTTCGAGGCGACACTTCT
BMP4 REV 5’ GCTGTGGATCTGCTCTTCCT
TGFBR2 FWD 5’ GACTGAGTGCTGGGACCAC
TGFBR2 REV 5’ GGAGCCGTCTTCAGGAATCT
SMAD6 FWD 5’ TCCCTACTCTCGGCTGTCTC
SMAD6 REV 5’ GAGAATTCACCCGGAGCA
DKK1 FWD 5’ CATCAGACTGTGCCTCAGGA
DKK1 REV 5’ CCACAGTAACAACGCTGGAA
IGFBP3 FWD 5’ GGTGTCTGATCCCAAGTTCC
IGFBP3 REV 5’ CGGAGGAGAAGTTCTGGGTA
GAS1 FWD 5’ TGAGCCGCTACCTGACCTAC
GAS1 REV 5’ ACACGCAGTCGTTGAGCA
SPHK1 FWD 5’ TGAGCAGGTCACCAATGAAG
SPHK1 REV 5’ GGCTGAGCACAGAGAAGAGG
Table A.2. Oligonucleotides for cloning
Name Sequence Description
H3.X+Y EcoRI FWD 5’ GGAATTCAGGCAATCGCTGCG
CGCACCAAGCAGACCGC
cloning of H3.X and
H3.Y cDNA into
pIRES HA Neo
H3.X BamHI REV 5’ CGGGATCCCTAGAGTGCAAGG
TTTCCCA
H3.Y BamHI REV 5’ CGGGATCCTTAAGGACCCTCT
CTGCGGAG
H3.X+Y HindIII FWD 5’ GAGGATAAGCTTCAGCGCGCA
CCAAGCAG
cloning of H3.X and
H3.Y cDNA into
pEGFP-C1
H3.X SacII REV 5’ GATAATCCGCGGCTAGAGTGC
AAGGTTTCCC
H3.Y SacII REV 5’ GATAATCCGCGGTTAAGGACC
CTCTCTGCGG
H3.X+Y NdeI FWD 5’ GGAATTCCATATGATGGCGCG
CACCAAGCAGAC
cloning of H3.X and
H3.Y cDNA into
pET-21a(+)
H3.X XhoI REV 5’ CCGCTCGAGCTAGAGTGCAAG
GTTTCCCAG
H3.Y XhoI REV 5’ CCGCTCGAGTTAAGGACCCTC
TCTGCGGAG
H3.1+2 HindIII FWD 5’ GAGGATAAGCTTCAGCGCGTA
CTAAGCAGACGG
cloning of H3.1, H3.2
and H3.3 cDNA into
pEGFP-C1
H3.1+2 SacII REV 5’ GATAATCCGCGGTCACGCCCT
CTCCCCAC
H3.3 HindIII FWD 5’ GAGGATAAGCTTCAGCCCGAA
CCAAGCAGACTG
H3.3 SacII REV 5’ GATAATCCGCGGTTAAGCTCT
CTCTCCCCG
H3.X+Y siRNA mut FWD 5’ GGCACCCTGGCGCTGAGAGAG
ATTCGGAAGTACCAGAAGTCC
site-directed
mutagenesis of
siRNA-target
sequences in H3.Y
H3.X+Y siRNA mut REV 5’ GGACTTCTGGTACTTCCGAAT
CTCTCTCAGCGCCAGGGTGCC
H3.Y siRNA mut FWD 5’ CTGGCCCGCCGCCTCAGACGC
GAAGGACCTTAAGGATCCACTAG
H3.Y siRNA mut REV 5’ CTAGTGGATCCTTAAGGTCCT
TCGCGTCTGAGGCGGCGGGCCAG
II
Table A.3. Oligonucleotides for RNAi
Name Sequence Description
luciferase sense 5’ CUUACGCUGAGUACUUCGAdTdT
control siRNA
luciferase antisense 5’ UCGAAGUACUCAGCGUAAGdTdT
H3.X sense 5’ CACCAAAGCCGCCAGAAAAdTdT siRNA targets
specifically H3.XH3.X antisense 5’ UUUUCUGGCGGCUUUGGUGdTdT
H3.Y sense 5’ CCGCAGAGAGGGUCCUUAAdTdT siRNA targets
specifically H3.YH3.Y antisense 5’ UUAAGGACCCUCUCUGCGGdTdT
H3.X+Y sense 5’ GCGGGAAAUCAGAAAGUACdTdT siRNA targets
H3.X and H3.YH3.X+Y antisense 5’ GUACUUUCUGAUUUCCCGCdTdT
C
430 440
- - - - - - - - - - - - - - - - - - - - - - - -
T C C T G G G A A A C C T T G C A C T C T A G
- - - - - - - - - - - - - - - - - - - - - - - -
130 140 150 160 170 180
C G C T A C C G C C C C G G C A C C G T G G C C C T G C G C G A G A T C C G C C G C T A C C A G A A G T C G A C C G A G
C G C T A C A A G C C T G G C A C C C T G G C G C T G C G G G A A A T C A G A A A G T A C C A G A A G T C C A C G C A G
C G C T A C A A G C C T G G C A C C C T G G C G C T G C G G G A A A T C A G A A A G T A C C A G A A G T C C A C G C A G
10 20 30 40 50 60
T G G C A C G A A C A A A G C A A A C A G C T C G C A A G T C C A C C G G C G G C A A A G C G C C G C G C A A G C A G
T G G C G C G C A C C A A G C A G A C C G C C C G C A A A G C C A C C G C C T G G C A G G C C C C C A G G A A G C C C
A
A
A T G G C G C G C A C C A A G C A G A C C G C C C G C A A A G C C A C C G C C T G G C A G G C C C C C A G G A A G C C C
70 80 90
C T G G C C A C C A A G G C G G C T C G C A A G A G C G C T C C G G C C
C T G G C C A C C A A A G C C G C C A G A A A A A G G G C G T C G C C T
C T G G C C A C C A A A G C A G C C G G A A A A A G G G C G C C G C C T
100
A C C G
A C A G
A C A G
110 120
G T G G C G T C A A G A A G C C C C A C
G A G G G A T C A A G A A G C C T C A C
G A G G G A T C A A G A A G C C T C A C
T
210 220 230 240
T T T T C A G T G C T T G G T A C G G G A G A T C G C A C A G G A C T T T A A G
C T T C C A G C G T C T G G T G C G T G A G A T C G C C C A G G C C A T C A G C
C T C C A G C G C C T G G T G C G C G A G A T C G C C C A G G C C A T C A G C
190
C T G C T A A T C C G G A A G C T A C
C T G C T C C T G C G C A A G C T G C
C T G C T C C T G C G C A A G C T G C
200
C
C
C
250 260 270 280 290 300
A C C G A T C T G C G C T T C C A G A G C T C G G C G G T G A T G G C G C T G C A G G A G G C T T G C G A G G C C T A C
C C G G A C C T G C G C T T C C A G A G C G C G G C C A T T G G C G C C C T G C A G G A G G C C A G C G A G G C C T A C
C C G G A C C T G C G C T T C C A G A G T G C G G C C A T T G G C G C C C T G C A G G A G G C C A G C G A G G C C T A C
310 320 330 340 350 360
C T G G T G G G G C T A T T T G A G G A T A C C A A C C T G T G C G C C A T T C A C G C C A A A C G C G T C A C T A T T
C T G G T G C A A C T C T T T G A A G A C A C C A A C C T G T G T G C C A T C C A T G C C A G G C G C G T C A C A A T T
C T G G T G C A G C T C T T T G A A G A C A C C A A C C T G T G T G C C A T C C A T G C C A G G C G C G T C A C A A T T
G
410 420
A G A G G G C A T A A - - - - - - - - -
A G G G T G C C G G A G A G C C C A C
A G G G T C C T T A A - - - - - - - - -
370 380 390 400
A T G C C T A A A G A C A T C C A G C T T G C G C G C C G C A T C C G A G G G G
A T G C C C C G A G A C A T G C A G C T G G C C C G C C G C C T C C G T G G A G
A T G C C C C G A G A C A T G C A G C T G G C C C G C C G C C T C C G C A G A G
H3.1f
H3.X
H3.Y
H3.1f
H3.X
H3.Y
H3.1f
H3.X
H3.Y
H3.1f
H3.X
H3.Y
H3.1f
H3.X
H3.Y
H3.1f
H3.X
H3.Y
H3.1f
H3.X
H3.Y
H3.1f
H3.X
H3.Y
Figure A.1. Nucleotide sequence alignment of human H3.X and H3.Y with H3.1.
Alignment of coding nucleotide sequences of human H3.1f (NM 003533), H3.X (LOC340096) and H3.Y
(LOC391769) genes. Identical nucleotides are highlighted in dark gray and changes are set apart on a white
background.
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Figure A.2. Amino acid sequence alignment of H3.X and H3.Y from different primate species.
Alignment of human (H. sapiens), chimpanzee (P. troglodytes) and macaque (M.mulatta) H3.X and H3.Y
protein sequences. Sequence similarity is encoded by background color: identical aa = dark gray, similar aa =
light gray, different aa = white. Note that the macaque H3.X ends, like H3.Y, after aa 135 (asterisk indicates
stop codon) but following amino acids would code for the extra C-terminus of H3.X.
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Figure A.3. Comparison of different microscopy techniques.
Lateral (top) and orthogonal (bottom) sections of U2OS cells, co-stained with αH3.X/Y (green) and DAPI
(DNA, blue), are depicted. Images were acquired using a widefield (left) or an OMX DeltaVision (right)
microscope. A deconvolved version of the left image is shown in the middle. Scale bar equals 5µm. Insets
show enlargements of boxed areas with scale bar equaling 0.5µm. With 3D-SIM resolution, but not with that
of conventional microscopy, localization of H3.X/Y protein outside of DAPI-dense regions is visible.
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Figure A.4. MS/MS spectra of H3.X/Y- and H3.Y-specific peptides.
NanoLC-ESIMS/MS analysis of propionylated and trypsin-digested proteins in
RP-HPLC fractions corresponding to region A bands from U2OS SO experi-
ment 1 (see Fig. 3.13Ciii). Depicted are MS/MS spectra of doubly charged
precursor ions of peptides specific for H3.X and H3.Y ((A) m/z=745.44,
(B) m/z=606.83) and unmodified or acetylated H3.Y-specific peptide ((C)
m/z=654.90, (D) m/z=640.88 and (E) m/z=647.90). Boxes on the right show
specific b and y ions after fragmentation.
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   Odds Exp
GOBPID     Pvalue   Ratio   Count   Count   Size   Term
GO:0000280  0.000  6.951  3  20  248  nuclear division
GO:0007067  0.000  6.951  3  20  248  mitosis
GO:0048285  0.000  6.710  4  20  256  organelle fission
GO:0000087  0.000  6.653  4  20  258  M phase of mitotic cell cycle
GO:0051301  0.000  5.937  4  22  318  cell division
GO:0000279  0.000  5.515  5  22  340  M phase
GO:0022403  0.000  4.767  6  24  428  cell cycle phase
GO:0007049  0.000  3.538  12  35  864  cell cycle
GO:0000278  0.000  4.671  6  24  436  mitotic cell cycle
GO:0071103  0.000  9.106  2  13  122  DNA conformation change
GO:0022402  0.000  4.019  8  27  571  cell cycle process
GO:0006323  0.000  9.123  1  11  102  DNA packaging
GO:0007059  0.000  10.287  1  10  83  chromosome segregation
GO:0006261  0.000  11.797  1  9  66  DNA-dependent DNA replication
GO:0065004  0.000  9.327  1  9  81  protein-DNA complex assembly
GO:0000075  0.000  8.952  1  9  84  cell cycle checkpoint
GO:0006334  0.000  9.422  1  8  71  nucleosome assembly
GO:0051276  0.000  3.453  7  20  470  chromosome organization
GO:0006260  0.000  4.924  3  13  213  DNA replication
GO:0031497  0.000  8.856  1  8  75  chromatin assembly
GO:0009066  0.000  21.496  0  5  22  aspartate family amino acid metabolic process
GO:0034728  0.000  8.475  1  8  78  nucleosome organization
GO:0006270  0.000  20.300  0  5  23  DNA replication initiation
GO:0009067  0.000  29.070  0  4  14  aspartate family amino acid biosynthetic process
GO:0051726  0.000  3.772  4  14  295  regulation of cell cycle
GO:0006259  0.000  2.988  7  19  508  DNA metabolic process
GO:0000070  0.000  12.588  0  5  34  mitotic sister chromatid segregation
GO:0006996  0.000  2.203  18  35  1311  organelle organization
GO:0000819  0.000  12.168  0  5  35  sister chromatid segregation
GO:0051318  0.000  19.372  0  4  19  G1 phase
GO:0009086  0.000  43.353  0  3  8  methionine biosynthetic process
GO:0006333  0.000  5.579  2  8  114  chromatin assembly or disassembly
GO:0006082  0.000  2.841  7  18  502  organic acid metabolic process
GO:0007091  0.000  16.139  0  4  22  mitotic metaphase/anaphase transition
GO:0007093  0.000  10.425  1  5  40  mitotic cell cycle checkpoint
GO:0007094  0.000  30.961  0  3  10  mitotic cell cycle spindle assembly checkpoint
GO:0045841  0.000  30.961  0  3  10  negative regulation of mitotic metaphase/anaphase transition
GO:0008652  0.000  9.599  1  5  43  cellular amino acid biosynthetic process
GO:0031570  0.000  9.118  1  5  45  DNA integrity checkpoint
GO:0007076  0.000  27.089  0  3  11  mitotic chromosome condensation
GO:0071174  0.000  27.089  0  3  11  mitotic cell cycle spindle checkpoint
GO:0009309  0.000  6.867  1  6  70  amine biosynthetic process
GO:0044283  0.000  3.415  4  12  275  small molecule biosynthetic process
GO:0016043  0.001  1.813  33  51  2371  cellular component organization
GO:0006555  0.001  24.077  0  3  12  methionine metabolic process
GO:0071173  0.001  24.077  0  3  12  spindle assembly checkpoint
GO:0019752  0.001  2.682  7  17  498  carboxylic acid metabolic process
GO:0043436  0.001  2.682  7  17  498  oxoacid metabolic process
GO:0010948  0.001  12.098  0  4  28  negative regulation of cell cycle process
GO:0007346  0.001  4.575  2  8  137  regulation of mitotic cell cycle
GO:0031577  0.001  21.667  0  3  13  spindle checkpoint
GO:0045839  0.001  21.667  0  3  13  negative regulation of mitosis
GO:0051784  0.001  21.667  0  3  13  negative regulation of nuclear division
GO:0042180  0.001  2.614  7  17  510  cellular ketone metabolic process
GO:0000097  0.001  19.696  0  3  14  sulfur amino acid biosynthetic process
A
B
   Odds Exp
GOBPID     Pvalue   Ratio   Count   Count   Size   Term
GO:0032274  0.000  166.667  0  2  5  gonadotropin secretion
GO:0042523  0.000  166.667  0  2  5  positive regulation of tyrosine phosphorylation of Stat5 protein
GO:0046884  0.000  166.667  0  2  5  follicle-stimulating hormone secretion
GO:0042522  0.000  99.983  0  2  7  regulation of tyrosine phosphorylation of Stat5 protein
GO:0042506  0.000  83.312  0  2  8  tyrosine phosphorylation of Stat5 protein
GO:0060986  0.001  62.473  0  2  10  endocrine hormone secretion
Figure A.5. GO groups significantly affected by H3.Y and H3.X+Y knockdown in U2OS cells.
Comprehensive list of GO groups comprising genes that are significantly up- (A) or down- (B) regulated after
siRNA knockdown of H3.Y and H3.X+Y in U2OS cells compared to luciferase control knockdown. For number
of overlapping genes see Venn diagrams in Fig. 3.18B. Size= total number of genes analyzed in this node (GO
term), ExpCount=number of ”responders” expected (entering the term by chance), Count=actual number
of ”responders” found in the node.
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Figure A.6. Alternative H3.X transcripts.
The annotation of the H3.X gene locus (LOC340096) in the NCBI database has changed several times over the
last years. Shown is a scheme (top) and an amino acid sequence alignment (bottom) visualizing the different
predicted H3.X proteins. Note that unlike H3.X, H3.X-1 and H3.X-2 consist of several exons. Identical amino
acids are depicted on a dark gray, similar amino acids on a light gray and different amino acids on a white
background.
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